PDF file - 東北大学

FBC Lett., No. 30 (2009)
2009 6 ' 生命化学研究との出会いそれから...
東北大学多元物質科学研究所
永次
史
' '人工核酸を用いたポリメラーゼ反応
~人工核酸アプタマー創出に向けて~
群馬大学大学院工学研究科
桒原 正靖
'シャペロニンを利用した機能性物質の創製
東北大学多元物質科学研究所
金原
数
'光誘起電子移動に基づく蛍光プローブの精密開発
東京大学大学院薬学研究科
浦野 泰照
九州大学大学院システム生命科学府
戸井田 力
' 大阪大学大学院理学研究科
町田 慎之介
東京医科歯科大学生体材料工学研究所
森谷 優貴
' IIS 型制限酵素を利用した全自動プラスミドコンストラクション
北海道大学電子科学研究所
'
小寺 一平
%#!$
2nd Switzerland-Japan Biomolecular Chemistry Symposium (SJBCS2009)/国
際バイオ EXPO 特別講演セッション/第 24 回生体機能関連化学シンポジウム・第 12
回バイオテクノロジー部会シンポジウム/FCCA セミナー FCCA グライコサイエン
ス若手フォーラム 2009
' &"&
受賞・会員異動のお知らせ
編集後記
t&6{~ąøĈ¸ ¸ No.30 (2009 June) 2
¸ `26ć/{Üje×ͺ'Ýt&6{~ąøĈÜ=²’Ü+‚Üdî¿ÑÒů>Û
a×ͺ–î¿ÑÒ¿Öáι¤ÛZÃëÑ=²’îäÀA˜âyËÖ¿ÇعÙÜ=²’Ãèä¹
xcÜt&6{~Û¬Íê1¹áÑ_{~܅YèËÊîMÌèë¹+‚ۮ˯>ÛĀąùöăĈ
îMÌáËѺ‹Øt&6{~ØÜÃÃíéÛտֆÁÑXÛ¹ÉÜ{~ÛÊëÖ¿êW»Ø
Ü¿Ä2ÅÃÔÑÉØîRãÖJ¿Ë¹}Øt&6{~ØÜ¿ÛÕ¿ÖZÃÏÖ¿ÑÒÇ
ÉØÛËáËѺĉ‹Ü'³©ÜçÀÚ8×u˔¾éáÏïĊ“OîÞäØ¿ÖâáÍع1995 ?Û¹{
~7Ü ×¾êÊïĉ2­@26ĊÛÇÔÕ¿Ö¹ãք(×Ü Bioorganic¸ Chemistry ÜõĈ
üĆóĆþðąĆ÷ÛËÑXÛ¹s)¹t&6{~ÜHØÚèëÖ¿êtWØ¿ËÑØJ
¿áͺDX¹b§Û¬Íê{~î4ãÖČ?ĤÆÉÜûĈā×-›SîZ¿Ö¿áËÑĹáÒá
Ò¡€×\d#P6ܱ*îžÁê{~ċÛ×ÅêÜÃÙÀù2.Lï׿áËѺÓæÀ
ÙÐÜXÛ¹ÊïÃè—íëËÑóĆþðąĆ÷×ݍ¿{~‡ÜW»Ä2.ñôûòÿ×¾é¹
ÐÜDX}ÄMÌֿѼ±*Ü,½ÜçÀÚäÜÝáÔÑÇÚǹt&6{~ÛÕ¿Ömw۝›Íê
ÜֹáÊÛzÃèÀìɹ×ËѺÉÜóĆþðąĆ÷Û×ÅÑÉØݹEÜ}Ü{~tî2Å
Ç.ÁêÉØÛÚÔÑØJ¿áͺĉš×ÍĹ0¹9Œ×´âÍÆÖ¹eÜ]¹œnäÅÃÎ۹ؿÀç
éäˆÈêrN×ÝÚǏÊïØýĈĂúĄĈÜ^Ü×iîÜâÚÄèBÔÖ¿ÑÜä¿¿J¿×
ͺĊÐÜE¹p¹-"î
F׏óĆþðąĆ÷×!ÈÑoî‰Û¹¦
5GÛ$ÈÑ{~î
;ªËÖ¿ÑÉ칏ÊïÃè¹_ÄwŸÍêÅÔÃÈØÚÔÑq_×ܝÜ–îˆÅ˹ä
äÚÇËÑ¿ØuËáËѺØÉìĹDXÝ3K×Ü|fĉ9lT¨Ä·ÇÚêĊØ¿À
ѿ’ŽÛ¹îUIËѓOľéáͺt&6{~ÄgCÛwŸËÖ¹ċ'¹2­×
íëÑt&6{~ۏÊïۗÔÖ¿ÑÒŹ3K×ÊÏÖ¿ÑÒÅáËѺ¢Ý£¿
äÜܹč?çé:ËÝ{~Ä¢â¹åÔئ
5GÛÁÐÀÚ¥ĉ<dŠKb§Ċܕµƒ
ÛÂÈêdŠî™ßÖ¿Ñ°×ËÑĹÉÜ×ä¿ì¿ìÚtWØ–îÊÏÖ¿ÑÒ¿ÑÉØî“O
ËÖ¿áͺÐÜE¹v6ÃèQé¹2003 ?Ût&6{~Û%ï׿ÑÒŹw‘ÊÏÖ¿ÑÒÅáË
ѺÉÜXä¿ÕäÜçÀ۝›Äk¶Ë¹[Eܜn‡ÒÔÑVvÊïÜw‘X«ÄàØïÙhÔÖ¿Ú
P#Y]½¸¾ƒ ƒ No.30 (2009 June) 3
š­‹£r8•ŸŠ¨—…P#Y]£”±ŸŠ°@†¥„P#£&•Ÿ~-£MŠ5
Š´Œ;œ¢¤ „£—°“¡ Šž«J´«®Š¨—…2006 . 4 D£*!#®E!#£
‹ž¯„Cx¬¡j¤Y]$ 9•š"´
Ÿ„bha v§°¶·¹¼´^œ’žž‰¯¨
—…““>.„!# R€¤Y]´¬°“¡¤}•”´7–ŸŠ¨—…[¤Y]¥{"SN´2
°?•Š+"´9•„™±´QŠŸt‚`„bh ¤s´l¢‹¡Š‹¤Ž¢Y]¤
K±¢¤ —Ž„#P”µ¥u\¤Â.|¡Š‹XŠB| “¤­‹¢¹¾»£¯d©¨—…‡«¤
ž¯¿9Àˆ£¥‰°\/¤:m¡WwŽ3n ‰°šª£„¢¢VT¤«¤Ž9 ˜„G—
°“²£¬¡9Žc—°¡Š‹“¡Ž
†‰¯¨—…¡ŠŸ„?•Ÿš#P”µ£Iis
®l¢Ÿ«®‹¡Š‹¤¥}•„f(9®·¸¾º—°šª„¨šÁ.¯¨—…=g¤oL
®ŠŸ«R€ ¥1—°“¡«
„#P”µ¤OpŽyŠŠŸŠ¢Š¡“²Ž
†‰¯„=g
Žz_£¢ŸŠ°¤ ¥¢Š¡5‹“¡«­‰¯¨—…
ƒ j¤Y]$´;ŸÃ.Žeœ„A†6©¥'¢Š¡“² —Ž„P#Y] UH£k´
;ŸŠš›‘°­‹¢„Y]9F´V<•Ÿ“±®«0¯šŠ¡5ŸŠ¨—…,q¡•Ÿ¥¦”³
•¢Š%£¢Ÿ•¨Š¨•šŽ„“±®«P#Y]¤¨—¨—¤S)´Z4Šš•¨—…
ogx¥§M:Q No.30 (2009 June) 4
* ! $/312 5 , :
+.-05&"%:
[email protected]
8(#)&
W}‘¿-žºa'
»ºakW}‘¿-JO;G71KQAO2–!ž*T
À¶†´*‘¿JO;G71KQAO2–SELEX – (Systematic Evolution of
Ligand by Exponential Enrichment)1,2 & Non-SELEX 8M15IO– 3 S•Ä8M15IO– 4 )‡[ÅY”±-%‘¿.D:FQ-Xƒ“ cvÇ:Q4=?È|eµ*
*ÇpÉȑ¿.D:FQš-ž*eb*
*˜&g
xl…'RËÊ73QLy]µ¼*
˜U™œ„~—^w*˜›Â
*
$¥§¹²&h²P¸Š²!ž
€+
*‘¿B1M.Q9Ǒ¿c·¾¬È
'[`{Œc·+#
zž
gu*¨¯(h²P¸Š
²©!ž-¡ˆ‘¿sq½&«½KO¿
½-gx_Æ*'B1M.Q9°
‚-mTW}‘¿.D:FQ-\µ*†´
ß-³*
8
*!$/3125,
w¤'‘¿B1M0<@,+*q
ŽiZ
KO¿6/7>L­l¢d®
c
v*Çp 2ÈB1M0<@sq½Z«½Z
KO¿½Z(…).O<8O7h²&‘¿DNQ
C!ž&VÀÁ…”’·‹-¡ +(½Z-gx _ÆP‰t¦
W}‘¿
rn+Ž¥§›+
(½Z!_Æ
EKHJQ9kj"f
£¡EKHJQ9'*W}‘¿ºa'
»ºaª
9 64 7'
”b\mšœD6F No.30 (2009 June) 5
3
' hf»N
SÁ_
(šœ+)7@E
O
O
&393E=C@4Ehf 5 N/8;E&
2/;E>CEhf 7 N
O
NH
N
O
¤‚fsU
r?CABF5Œ¶˜qp*™(+
*y+(»N«Tf.sU<1
NH
N
O
O
O
O P O P O P O
O
O
O
O
TTP analog
OH
D03:HCE½±sPˆ½«T‹³\°ª
v´+*Ãd 3ÄG§+(°ªk
O
O3S
SO3H
N
N
efµHCE½ÃdATPdGTPdCTPTTPÄW
lI•*$«Tf DNA ¾Lºxž~
S
U+**R«T‹³ TTP O
NH
±sP. 4 ›Àke dNTP W•gaT NH2
U+*!,ke T U)SÁ
e T U)**«T‹³\
«TfUž~n"%Vc¿
­. SELEX 
iJ¼a*y SELEX 
z•*gaj
N
O
O
O
O P O P O P O
O
O
O
N
O
N
dATP analog
OH
4 '
./'
z•*ga
•*SÁefµHCE½rz*kefµHCE½€?CABF5]z.¬"
)TTP ±sP.Q•*ke TTP .dATP ±sP.Q•*ke
dATP .€]z.¬+T U+*!,VSÁe T A U+*!,VSÁe A U+**
(ƒ
4 ›ÀkefµHCE½SÁefµ
HCE½.ŽZ*Y·ƒŒ!
?CABF5]z[“jOI
*
¥(SÁf—*›
SÁefµHCE½.a}+(.•
?CABF5]z.Ÿ£˜‰¯
*']z„º\.°#
¢‡SÁf\mŠ¹&?CABF5
›À"+(¡#a-]
5 #+.,-0*&($
z^“&{ow.ju`*
X
’?CABF5›À
_ © Ã Thermococcus
kodakaraensisĖ…¦‘| DNA ?CA
BF5ÃKOD DashěSÁfµ
rrz*Mtˆ½.Â{ow
^ҬK*X
(¥(?CABF5'*S
Á DNA ”}]z.¸w²˜®†*
6 !12)"%+.,-0*
´qh¹½M<P No.30 (2009 June) 6
*kŽß¼
l³)‰‹é1j$-1À¤Ä¢]ë
w
DNA Yæ垾ZÆ-FLIKP;Ð|g³
É[S-ƒ]
ëw
ävå`ZÆ-Ð|g³%,[S
dît 4ïÄ¢
z±v DNA 1äv]ë DNA 1´‘-kŽî×cï*,(]ë DNA 1ävz
±v DNA 1´‘-kŽîÚ×cï—
-‚™-1»-ît 5ï
( ÁáZ1]ëU‡¥ã1µFLI
KP;kŽVTÂa,Àf·Ë0.
-*KO=H:6LPBO7®
#Žµ)×cî!ÇÑï9:?H
“ŠFLIKP;kŽ«¨Ï˜
¸·-¿È+–-Á
áZ]ë3AN7²¥ãiÊ#
Žµ
œÎ.-£ªv¥ã (BNA:
Bridged Nucleic Acid) 7 1µFLIKP;
) &#'"$%
kŽ1¦Òì£ªvC6M59
@RLOãԄ\îKTP, LTP, MTPï*"
£ªvC6M5>@îKLMKA ï1p
'ävå1µît 6ïÄ¢KTP
1µxn 3 ­wLTP 2 ­w
MTP 0 1 ­wYæÍ+.
ît 7ïQ—£ªvC6M5>@
1p'ävåkŽ1Ë/£ªv
* &#'"$%!
C6M5>@
ÝÅ~u-ävå
5ñ9 ­w¼‰Yæ
_¬
ð- 2 3 £ªv
C6M5>@1”a(1ävåµ
/KOD Dash DNA FLIKP;
*"y¶\1µ.
<4E L £
ªvC6M5>@1èkŽ
›Œ%Þ
ˀbæYæå
ºÓ.ît 8ï
+ oàX}ÞhD2GLPB †-
Vent(exo-) DNA FLIKP;(o©Yæ
ºÓ.
܉ϡ*,eÙâÃ*,(Õm
,Ø&îG:4O8PFMP9JOï1´)
»r.
…U‡¥ã1µê¹½
ۈ 50 ^1Ö-íâð‰)ðšç1
Ö-ækŽšç§¾ W
µ+.-
-¯1’Ì
-s&
ŸìkŽšç 5 dçâð‰•{°‰ 10 ^Ë
µv½À]I` No.30 (2009 June) 7
'$(FCD6" [_ÝÛl%qæ$&SES^J=;`
L„=[BO@]=JMêPS-ODNë.TZ
PQ<EQ :`L„ =[BO @]=JM
êBH3--ODNë#"2ê‚ 9딚2
O@]=CMb[_Ý4¶3'Üƺ
$30%h–¦Ý4ÔÏ2!zÌ
2 930%h–¦Ý4¶7_J
G_E.7RIV`#"%ªÌ›¦Ý4n
Ï2‡{''-[_Ý%?Z[K
8å!#2sº$ÅÃ#7N^A
-â¹32‹‰èp
I# .8/84CD"#
2SE
S^J=;`L-TZPQ<EQ:`L[_ÝD;EK\ӕm
2%i$-¿
%È{
%Ûl4É h–¦Ý¡Š
2³$®Õº{œ“¤#7WMÈ{.7W_È{#"
É =[BO@]=JM&¼
ΦÝêDNARNAë!%²‘›%+#0%gÞà¨×êNMRë$-ÒÇ$?YZ
@IZ9F32DNA àf%30%È{U[XZ`Hyš$x*˜ä$
&¬"†~o#
ÁË0&RZ9V`à.߄à%[_ÝD;EK\È{4
7WMÈ{2&7W_È{$É ODN 4{œ304¶U[XZ`Hyš4§
Ñê‚ 9ë[_ÝÛl$230%É …%Ÿt&ˆ…Ûlqæ.ÄÛlqæ/1-
!káyš4ŒKOD(exo-). Vent(exo-) DNA
U[XZ`H&߄àc%ŸtÉ …4ÖÙká
à4µœ#0ˆ…Ûlqæ.ÄÛlq
æ!‹¸#2±&ÜÆÖٙ-߄àc%
ŸtÉ …&d¯%káyš4—°!
2‚
10 $%ao4¾ÜÆ$ KOD(exo-)2&
Vent(exo-)4¶‡{7WM„[_>`4 1 },
߄àíêë/(îêë &É …Ÿtu
™
%kár«&)!5"Ð03#%$”7WM
„[_>`4 2 },߄àïêë
…Ÿtu™
&1 ·»%É
)!5"ká&r«# 2 ·
»%Ÿt%žu
ðìòñìé-%kár«Ð
03w3& DNA U[XZ`H 2 ·»%7
WM„[_>`c4ÖÙ2ã1 ·»%7WM„[_
>`%Žƒkáyš4—°2!¾€
2¢´ 10 $/2!¥É …4 1 ­…Ÿt2!$/
2 DNA gÞà%ͱ‰vêTMë&-0.1ò+0.9
2%
É …Ÿt$/2gÞà%e‘v&)!5"
#!Ê032a£|©%’ç4ÚjØvQ6
W[`A % Taq DNA U[XZ`H4¶‡{
&
HG# ;@>CD<E:9:
5-1?CABE=#
J*K7;@>6:0,!7 ) !+7 37+
376 &% 321,#
²spº½O<Q No.30 (2009 June) 8
"çwè÷øùôõ)ɕx”b¿’"k[é`¤Ó,/.
gšÅŸ
ª¸&#çwè÷ùôõ1¨Ú1 ´¸"ɕ
x”b¿’"kkË# 45ó"[é`¤"!ŠË# 75ó)"[é`¤
Ó,//# 2 ´¸"”bɕxS«"[éq‹1†¬.1»t.
X Ç¢ÞԞ,# DNA FMILQ; 5 ¦x)T«"ɕx”bã\1Õ×.
#Êï,/# 2 ´¸"ɕx”b!+çwèc]!),/.o·“o"{
p[éq‹!Uj!a(‘#DL3GQè/çwèÒr],Ôî DNA FMI
LQ;e%Òr]!Zr.q‹1”bɕx}.(Ê.
çwè"EJ8Q6P9ôT "ßÆähõV!É•x1”b.DNA FMILQ;"9M
=DðÈ!Ó,/,DL3GQè/çwèÒr]DNA FMILQ;ë"¹W^³!
MPæx#¥Ù"¥"+
ˆl1Ÿ.")/
±vDNA FMIL
Q;"{µ]1³¢Þ£Î"¹ì!À .
/'!¾Ë,#yxã1_ñXƒ¡æ"L3CLM1³ SELEX ©!+82
MNL4?Q9*7M@G3@ւ]5N<HPæ
1mf
11-13
!¯µ·!År.Xƒ¡æ2D<GQ
/,"Xƒ¡æ2D<GQ#"®Ø"²]d*ÄÍd!™.oŽ*ˆl
1º½.("›³
g~>QNœ‰/.
/'"º½ÅŸ1ʏ.FMILQ;q‹Áã\*MPæã\1_ñXƒ¡æ
1å÷!r.#Y"0ïi—/.ôu 5Aõ
/,"Xƒ¡æ1݄"
SELEX ©!ⳡæ2D<GQmÑ1u."#'-±€·#
ôu 11Aõ
R˜KOD Dash +% KOD "{µ]1³/$/,"Xƒ¡æ1çw|­w DNA
"¹Ðè1n°+å÷!r.gôu 5BõۇSELEX ©1³
2D<GQ"94MQAP5©ôNon-SELEX :O48KP©öR§í:O48KP©
¶//,"˜©#:O48KP"ÜVἡæg~1z….–^
Xƒ¡æ1å÷!r.ϼ
õê
(
ôu 11Bõ±v¾Ë,#/,"˜©!+yx
ã_ñ+-,!B4O2Q;̌"òXƒ¡æ2D<GQ"ê¶1à(.
¡æ
¦d\n¯µJ9M No.30 (2009 June) 9
”Ó/C9DM!?3J/M8¹!cN›»„z"R}'ÔėÆÊÞ
,k{W
mÉÍ».'”Ó/C9DM.rÙ S,›»Wmr§\,Ná„z
.'Qx”Ó"ljâY¬
,G0BGH!73HM>K4Ÿ!Ö«
”Ó!£Yn¬oq\1@I2M(Wm:0=E37
)Ðs’¼f
ZQx
h™Ñ›»!®×;M9!Û´
Qx”Ó/C9DM.ÇÅLXÂ]ªßeÁ¦¥ih°¯µ
šWÕ$vր§-,|-,
‘¯µ.Ò&,
+¤¶¿‹ŸQ³nƒÀ…½›™äJST傩¬Xѯµ‡ÒO˜TQg
¯µäPRESTOå
™Ñ›»Å W“)+kl,~Šˆ.`%%­,~݉
*#
~[Y.Ï+%¸àlnbȌ† ¡P pŽ U¦)#alnŒ† uw yŽ U
¦lØlnbȌ† Rà  U¦alnŒ† tžÎ º U¦
)+^~±¨N%
1.
A.D. Ellington, J.W. Szostak, Nature, 346, 818 (1990).
2.
C. Tuerk, L. Gold, Science, 249, 505 (1990).
3.
M. Berezovski, M. Musheev, A. Drabovich, S. N. Krylov, J. Am. Chem. Soc., 128, 1410 (2006).
4.
A. Nitsche, A. Kurth, A. Dunkhorst, O. Pänke, H. Sielaff, W. Junge, D. Muth, F. Scheller, W. Stöcklein, C. Dahmen, G. Pauli,
A. Kage, BMC Biotechnol., 7, 48 (2007).
5.
M. Kuwahara, J. Nagashima, M. Hasegawa, T. Tamura, R. Kitagata, K. Hanawa, S. Hososhima, T. Kasamatsu, H. Ozaki, H.
Sawai, Nucleic Acids Res., 34, 5383 (2006).
6.
M. Kuwahara, S. Obika, J. Nagashima, Y. Ohta, Y. Suto, H. Ozaki, H. Sawai, T. Imanishi, Nucleic Acids Res., 36, 4257 (2008).
7.
S. Obika, D. Nanbu, Y. Hari, K. Morio, Y. In, T. Ishida, T. Imanishi, Tetrahedron Lett. 38, 8735 (1997).
8.
M. Kuwahara, H. Takeshima, J. Nagashima, S. Minezaki, H. Ozaki, H. Sawai, Bioorg. Med. Chem., 17, 3782 (2009).
9.
¡PpŽæ–_œÜæ6AF5E7<HMÌ˲æוVÚLã¾¢· 157 (2003).
10.
S. M. Freier, K. H. Altmann, Nucleic Acids Res., 25, 4429 (1997).
11.
M.M. Masud, M. Kuwahara, H. Ozaki, H. Sawai, Bioorg. Med. Chem., 12, 1111 (2004).
12.
A. Shoji, M. Kuwahara, H. Ozaki, H. Sawai, J. Am. Chem. Soc., 129, 1456 (2007).
13.
K. Ohsawa, T. Kasamatsu, J. Nagashima, K. Hanawa, M. Kuwahara, H. Ozaki, H. Sawai, Anal. Sci., 24, 167 (2008).
V!.^aӾք „ No.30 (2009 June) 10
2546371(*,
×[email protected]Ø
98 -)/+
„ ¾Õɶr¢I‡Ÿ‚KHv°B”œŒ­…–¯—¯ŽRm¡cHv %›Jk°B”œ‰®†’
¡«ŠŸMh“¯˜HvžJk°;W•®ž…1P¢­7Ÿ‰«ŠŸÆȽ¸ÖÒ¡Jk8
HvP°­•’žŽ®†:‡¢…¼ÎÌÔÇ՞
£¯®dQ¾Õɶr°W”˜Jk8Pr
¡|Z°o™œ˜†C_¢…’¡ÀÏÖËQ¾Õɶr°W”˜Jk8Pr¡|Z š‰œg
•®†
:8 254637
„ ¼ÎÌÔÇÕ×chaperoninØ¢…y dQ¡b,°B•®dQˆ®‰¢T
Q¡2)¾Õɶr~ˆ­…V
+JG¡šž”œ]¬¯œ‰®[1]†
)lnXE¡GroEL¡&…7š¡»Ë
ÐÇÁÄ×60 kDa؎”œÅÖÆÁÂ
Q¡UQ~°­…“¬ –¯¬Ž
š`§zŸ™˜¿ËÒÃÁ´Ö$¡
dHv°49”œ‰®†d¡‚“¢
e14 nm…(6ªe14 nm…* ¢
64.5 nm x •® 2 )Ÿ b ,Ž 3
9 254637 !%$ " '0. !%$ "&!%$ # ,
Ž™œ‰®×"Ù؆+{¢840 kDˆ
­…¾Õɶr¡¢Ÿ­)Ÿy 0•®†fj¼ÎÌÔÇÕ¢…'8¾Õɶr¡ÑʳÖ
Òòշ°;‘•®’žŽ]¬¯œ‰®†¼ÎÌÔÇÕ¡b,­
u¢YL8Ž‚…'8 «™œYL€Ž”˜¾Õɶr°/@ =¬‹®’žŽ®†’’…¥˜¡5°F˜•º¼ÎÌ
ÔÕGroES¡-#ATP°N•®ž…dŽHv'°s’”…'8¾Õɶr¡ÑʳÖÒòշ…Ÿ
¬¤ b,¬¡ÑÑÖ½Žs’®†¼ÎÌÔÇÕ°D?ž”œ<‹˜ž…¡D? ¢q¬¯Ÿ‰ƒ
[ŸO¢…ÙØ\64.5 nmž‰Š2)ŸÆÈb} ¹½Ä°­t¨’žŽ®…ÚØ ATP°‹®žb,
¡4Ž'”œP°>•®…ž‰ŠÚOˆ®†’¡«Š JG[ •®2)ͽÄ+°
1[ 9•®’ž¢SAO¢kˆ­…I‡Ÿ¹½Ä°w¦˜©¡µÎѱ¡pž”œ¼ÎÌ
ÔÇÕ°W”«Šži‹˜†
:@A˜†›Y Y No.30 (2009 June) 11
-+"'$( [2]
Y „–™‹š0G&-*nel%;g}mUNp6
sZ„–™‹šrBq&†šŽƒQns=p}
!8
eZi~ATPqzkl)
mb}`o^`Zn
]^cnq\}[icmZvh(xqZ(Wpbdr
ŠŒDœCdS
elZŠŒDr
}nnyqZATPq%flŠŒD)
g}Z>ŠŒD
MrPLOwj[CdSCr
ŠŒDsK
6 !0+2(35')$*3#
3!0+2(3.4"
&,g}jxZ„–™‹šqz}|SwZ)

/
g}ra+m\}[9
qCdSIRqs25&aun
a)
b)
€op]jxZ„–™‹š`
{)
d~jqs#q
c)
31nelEqV`~}c
na'd~}jxZ•‹†›
nelTel]}nF_j[v
hZ25&5m\}…”‡
20 nm
—‘—“‚’‰mPLej
CdSŠŒDœ?$2.2 nmZ
Tris-HClœpH 7.5ˆ›
rHJ<.tqX"
7J<.„–™‹š
50 nm
- T.th. cpn,CdS )!* *
&%# T.th. cpn
œGroEL, T.th. cpnn4eZ
7 /(%4 T.th. cpn5CdS ')2,& 1-a) ATP b)ATP Q!+WYʲÍv v No.30 (2009 June) 12
¬É¡q‘œž]dƒ‰xˆ’^>wTEMÎ"ÓÏ}œ”ª
a
Ë·«Ç¾¥ÍÎ"ÔϑœžVU…Ÿ­ÆÀ˺Ìй
a)
HO2C
trans
N
Photo Gate
»\(e
4 ‰¢Xiƒ‰xŠ˜‘w­Æ
N
N
cis
N
Photo Gate
CO2H
UV Light
( = 350 ± 10 nm)
À˺̒*#ƒz=ŽCdS¹»\(’®Å³ÁÉ
GroEL
Visible Light
( > 400 nm)
GroEL
ĤøKH¢¼´¾£Í‘L…Ÿ2‘GDQ„
‰x4 ‰e
“NU‘,-ŽyžwGroEL’e
Ž“50 °CwT.th. cpn’e
Ž“80 °Cn—Žw
b
cis
b)
Open
GroEL
&7wg›¹»\(’:“l~‹‰x 
[1,1]-state
’J1“wÁ¯·’­ÆÀ˺̒bNJ1.6ƒ
+ ATP & UV
trans
}žwe
’,-7­ÆÀ˺̈’š’’,-7
‘œžF—‹zŸ~‹‰x‚w’œ{‘, ­ Æ À Ë º Ì /CdS ¹ » \ ( e Ž y Ÿ  w  ’
Tris-HClÎpH 7.5ϼ´¾£ÍEKH‘ATPwMg2+¦¨Ìw
trans
+ ATP
Closed
GroEL
+ UV
cis
[0,0]-state
Open
GroEL
Closed
GroEL
[1,0]-state
[0,1]-state
+
K ¦¨Ì¢Iƒ‰¡w‚ ‰CdS¹»\(
2‘:‚ Ÿ¢fƒ‰x’twÁ¯·’­Æ
À˺̓ˆ’@o¢‹zŸ~‹‰x’œ
E %!5:<A9A0'&!5:<A9A
7?=@;A0/*-D06
>B8
'
{:lŸ=“wATPwMg2+¦¨ÌwK+¦¨Ì’
a*#…Ÿ€’˜Žyžw “Q
Ž­ÆÀ
˺Ì&7²Ì½ªk‘Ⱦ§Íɶ¥Ì«¢p…Ÿ
=
AŽyŸx’œ{‘w­ÆÀ˺Ì0O‘
.ƒš&7²Ì½ªk‘.…Ÿ’
A’B@‘œžw
¬¯·’žm˜w‚‘:¢ATP‘œž5Ž€Ÿ
~‹‰x
DC7?=@;A0/12 [3]
v ­ÆÀ˺̓ATP‘œžwOk’žm˜w:¢
5Ž€ŸwBc7Ok’©ÆȤ͏ƒ’R¢`
|ŸwOPUM‘œŸ5Ž€Ÿ–{'—ƒzx
ˆŽw ATP6[7¢<…Ÿ­ÆÀ˺̑‚‘6
[7¢ƒwˆ’Bc’5‘Œz?h…Ÿ
‘ƒ‰Î"ÕÏx
v GroEL“ššÓŒ’­¯µ¦ÌC%¢<ƒzŸw
—† ¢…•¤ÇºÌ‘_9ƒ‰3wZ)ž
nÎÒÓÑSϑ­¯µ¦ÌC%¢;‰‘Œ/ƒ‰
&T
¢8ƒ‰x’&T
‘.ƒwÂʦør¢
<…Ÿ¤±¿Ì°Ìj/
¢R‚‡Ÿ‘œžwž
‘6[7¬Í·ƒ¤±¿Ì°Ì¢/ƒ‰u
­ÆÀ˺̢4Ÿ‘8ƒ‰x’u­ÆÀ˺
̑&7GFP¢|‰¡wsQ$’­ÆÀ˺̏
A‘ ¢žm™Ž€Ÿ¢Xiƒ‰x
F #"$ 00'%!+3,3
D0' &!).4
(-'
a)8ikñÚô™ ™ No.30 (2009 June) 13
™ ÊÙæóØó·p2]<µÁÚÞîóÖ¡ÂÔÖºš#|]<µÁÃÔÖ¡ÂÞîóÖº³š
]<WÈ¹¥³µÁÃ#‰fµdFÈD²£Ä›ÞîóÖ²·5¢V‡f¤šÔÖ²
·V‡fh¤´Ä­¾šp2#|]<µÁÚÑôÞ¶¦È#‰fµÒóÞòôð²£Ä¥³µ´Ä›
w(Y¥³µš¥¶ÊÙæóØó–ÔëçòàóÈbÄ¥³²šÑÖÞ³§±b­1FGFP¶J
‹AÈ]<µÁÃD²£Ä¥³¢¡¯­õ+úö›¼©šATP¶B”µ°±Q~§­¢šp2š
#|©ÅÈ]<§­0&µ¿šATP¶7-§´0&µ·ÑÖÞ¶J‹A·R¾±Œ¥³¢
¡¯­›¥Åµ;§šATP7-šp2È]<§±ÊÙæóØóŽÈÔÖµdF¨Ä³‹À¡
µ1FGFPÈJ§­›¥¥²š#|È]<§±ÊÙæóØóŽÈÞîóÖµdF¨Ä³šJ
‹A¢x§¤¨Ä¥³¢¡¯­›¥Å¶qO·šATP³p2È$³§±{­³£š«¶ø
°¢ŸÂÅ­³£µ¶½õ1FGFP¶‹À¡´Jö¢„¥ÄAND‚`*†¶Áž´En³½´
ªÄ›No·š5SP¶
Ȃ`*†µÁ¯±D²£­¾±¶µ´Ä›
$"'(%)! [4]
™ \¶e{²œÄ¢šù•µr¤ÔëçòàóSu¶Dµ‘¨Äik¶Š²š8–§­1
dÔëçòà󢚏?ÌÎó¶ZµÁÃ÷TfµK§­Ûìôå_¶“&ȟĥ³È{
®§­›š«¶qOµ°±>§§¤ˆ»Ä›
™ •µ ±šEnFŽ³§±ÊÙæóØóÈb±­›¥Å·]<µÁÚÑôގ¶^`
f´¦È3£¤1¦ªÄ¿¶²œ¯­›¥Åµ;§š]<µÁÃRF¢3£¤1¨ÄäÍÞÏòéÜ
Ï5³§±ÖãòãîóÈ=¨Ä¥³ÈtŸ­›¼©š4\.ÔëçòàóGroEL¶%ÓåíàÜÞ¶
ÔÖÝÌóȨ»±ÊîàóµsI§šLµ311cg¶ïÕó³314cg¶òÌÔóÈÔÖÝÌóµsI§
­GroEL1d(+û)È
z§­›¥¶1d²·š–#u´ÔÖÝÌó¢}28m¶l6¶Ã
"µ7-¨Ä¥³µ´Ä›¥¶Ôëçò
àóGroEL1dµ;§šèñÌéߎ
ÈM¨ÄÖãòãîó=ÈZ
¨Ä¥³²õ+üöšÔÖÝÌóU/µÖ
ãòãîóÈ=§­›–Cšp2#
14.6 nm
4.5 nm 13.7 nm
|'!ÖçÏÞðÈ[9§­³¥ÆšÖ
ãòãîó·N:—o²b§±Ä
áÜäÉô²Ž¢vefµêòÔ
Êàó.µdF§šo²·@µÖ
+ GroEL ãòãîó³êòÔÊàó¢7§­_
GµœÄ¥³¢Ç¡¯­›
™ –
O
E¶j€·ÓÌ×H’.…
˜,˜‹XÏòèÞÐîäËô(GPC)
N O
µÁÃy¯­›¥¥²Úóâσ¶'!
W²œÄ280 nmš Á¸Öãòãîó
O
.5¶'!W²œÄ350 nmšL
µšêòÔÊàó.5¶eW²
œÄ654 nm („ 381 nm)²«Å¬
N
O
365 nm
NO2
> 400 nm
N
O
N
NO2
O
, ' &(*#'(
5 9<§”ªa a No.30 (2009 June) 14
J a)29B9ACG>B0+6C0?;B6C"</70-=* (EF%$EF#.B<4/
A=9C.K&" EDTA *!#.B<4/A=b) "%'&)!</70-=
#EF%$EF
IH 0?;B6C583@D:# ,>D1
‡¨ —¥¡‰3!ob
_*j|NBowe†my‰:Josc
_'}$3!|ƒ…b
GroEL7}’“–‹©}hƒr³²«j
_n‡we†myjiusc
a _'}m}7GroEL| š’Œ¡‰2osymˆbGPC¨ —¥¡x`S,
}jAokos¬³­cn„|MO\^(V|ƒ…b
_GroELj@#Z;obWe•¤
ªž4}j%,owe†my‰Eos(°¯)cI=|0Gos>/bm}ƒf{•¤ªž4
}%,|~bq“¨¥©®¢¨’Š™©|ƒ†
_j)]xd†myjiuscn„|2
p†T"|vew0G‰Bus>/b š’Œ¡tlx{kbŽ¦’Œ¡‚U{z}±
}T"‹©}2j/8xd†my‰Eetoscm‡„}myi„b˜›•¤ªž%,|~b“¨
¥©®¢¨’Š™©PyT"‹©y}QjXowe†y?g„‡†cmmxb˜›•¤ªž‰%
,osH.|EDTA‰2p†yb˜›•¤ªžjF[p†myjius¬³­cm‡~bEDTAy}Q
|ƒ… š’Œ¡‹©j…Yi‡sxd†y?g„‡b˜›•¤ªž}%,|hewQjR
D{&‰-uwe†my‰Clwe†c
a 1|b’£Ÿ¨™©j+”©œK‰…L€my‰6owb’£Ÿ¨™©˜›•¤ªž|‘“—‰
j%5tyëØîŸ Ÿ No.30 (2009 June) 15
:´Ê±¼ÎÄ·¢
õ¡ÑÖmV¿/E
-lactalbumin Î ˆ éáê³ð¿˜<
ÐÒí¿4)³½§U
»¡×ßìßéíïå
ìÖÏÜíœGroEL
¾©·¼±Ì¡2c
*GroEL¿-"¼#[
¾É“ÃËʱ¼¬
33 a)!-lactalbumin #,&+'$-#%0,
)&/-b)!,&+'$-#-lactalbumin #%0
,)&/-4
.*(14-lactalbumin ".*(1
«¹·¢±¿eG¾.
ãÔÝÖÑäb³
· ¼ ± Ì ¡ / E -lactalbumin ¾ m V ´
ʈ»æÜØî³·ÓìãÚÔé䬡|0$»æÜØî³·ÛÞÙèîà¿ÓìãÚÔé伖½Ê
±¼¬«¹·¢´½Í¸¡/E -lactalbumin¬É“ÃË·ÃáÛÞÙèîà>H¬±Ê±¼¬
«¹·¢±¿Ç¨¾ÖçâìÜí¿R1¿dC»¦ÊÕ×ÚɓĂÎk³ºÛÞÙèî࿾Õ×
Ú3Îɓöʱ¼¾H³·¢
2
Ÿ ÖçâìÜí¡d¾GroELÀ¡QZ”¬Os»¦É¡j¾ª¯Ê?¬Ž}¾YŒ²Ëº§Ê·
Å¡[£F,Î9P¾Aʱ¼¬»­Ê¢²È¾¡67E¬ž®ÉI§Æ_‘q9P»¦É¡1ƒ‡Î
¹·1—piÆ!‚»¦Ê·Å¡[£½/oÎ1—¾Aʱ¼¬»­Ê¢'~³·/o
Š
ï5œ¼§¨•¿a˾ÇÉ¡ÖçâìÜí¿Z”qd…¡ATPDzE¼§¹·f„¿q½E
Î`«³·¡N³§q]‚TMŠ¬!‚»¦Ê±¼Îu´±¼¬»­·¢@À¡ÖçâìÜí¿
j‹&EÎ`«³·8kq½Dk¿;™Î(¹º§­·§¼€©º§Ê¢
Sx»~³·9À¡W1515š=5{tyw¿rlKJ¼Æ¾‰½¹·tyHX»´¢
÷¡#ty¿W’=1515š=5tyw¿hl^LjªÇÁW1515šN›
+Hw5tyw¿l
†\j¾±¿-ÎɺBvn³°Ã´¢
¤€Lg¥
[1] Braig, K.; Otwinowski, Z.; Hegde, R.; Boisvert, D. C.; Joachimiak A.; Horwich A. L.; Sigler P. B.
Nature 1994, 371, 578-586.
[2] Ishii D.; Kinbara K.; Ishida Y.; Ishii N.; Okochi M.; Yohda M.; Aida T. Nature 2003, 423, 628–632.
[3] Muramatsu S.; Kinbara K.; Taguchi H.; Ishii N.; Aida T. J. Am. Chem. Soc. 2006, 128, 3764–3769.
[4] Shuvendu Biswas S.; Kinbara, K.; Oya N.; Ishii N.; Taguchi, H.; Aida T., J. Am. Chem. Soc. 2009, in
press.
¥sm|¬¯WL[ No.30 (2009 June) 16
+-1"(
%/
0'&#!
.
([email protected])
32
Ā¥s£Â5¾”=¨Š»t5¾
‘324/
¥"/@¢Š5¥¡
¿Ž4$@®5¥¤‡¡Ã5l
ŠCUEVLFR4½ž(@%1!˜;
/Ë»0@%1!ƒ#ÀÁ&A@>
43-/@%5>3½žC}£
(@Œœ1'/£v½žÂizCÐ
‰‚4p¼m(@¸fQX[PC¦/
¸f΅Ì]0¥²µ†°C½ž(@Œ
œ!#›¦&A/@uÓ\4¸
fQX[P¸f΅ÌC¦/¥"
/@²µC¥"+::½ž(@
‹œ5n¤C±Ÿ4:1;+½žÂ
1(@¥¤‡izÑÒ5—hC´
@1"81D25¥¤‡¡Ã6 ·
0@+;f|΅Ì0+,½~'/
<*5l"C«@%16h“3!’
9 3462(-),.$*&:78 *
0153462 "! ,#015+%'/
8
‹œ6e6 ¸f‡0?1o†Z³r(@%10j;/¸fC©(@izѸfQX[PÒ
C²µg4{v&)@%105l"C¸f5xm1'/Љ‚
.UEVLFR4Æ%1Cp
¶1&)@<50@
b7FGY!²µg5ˆw`ÈCq@_ºª3KHYNSMKYJT[1'/d/@%
164§5 ^}0@!%A6 FGYCɍª4¸f—hp¶3¸fQX[P5Í©
4>@1%B!˜;/y"_ºª3 FGY—h¸fQX[P0@ 5™Ç1 FGY
—h5n¤Cu ]4­'+ 6OVGWKFYϖ1 FGYIW[L[0@ Êa
1!¹r'+™Ç0@!OU[5¢Š0689 ¸f0?%A! FGY1³r(@%
10*5¸fƒ‚! c4\(@+;FGY—h¸fQX[P1'/š¶(@ 42+-1"(
,%*)
$
\Å5>4¥²µ½ž4˜;/Ë»3„kC•+(¸fQX[P0@!%A:04Í©&A/
̖‹žÔÚh\l No.30 (2009 June) 17
(4·¾£…ç~dilc>B:O;? ´¨9ÿÐ-L8(8%J¸E>¾äN
ŸÉ/Kç~dilcNÇ68ÿÐ/K,:?¼F8˜Ă9!64,>ÊÎ:.8És>¶³>ü
‹žíÞNĆx.8G³4<·¾‹“Ä>ç~Å­q9G3>µK-Ĉç~üÈĉN¿Ö=
rÂ/K,:?BCpä9!J3LI³ëÄõNŸā=“®.ç~Å­NŸÂ.8EKD9~
K&~I<"&?M&I<",:'!+ILKH68,LD9}
?Ãç~­9!J:Ž¬k
á“/K,:9†F8ç~NÐ/Kç~dilcNÿÐ/K=?ðèþò=›7),:'mÏ>øú
9!64',>´Á9?³4<»„¡ô…Nì‹/Kç~dilcNÿÐ9(Kzï?)Ã)
Ÿā,LD9=ÿÐ-L8(4ç~dilc>\lV]`?’Ù‚šý¥PRj<;Ą§=ĀIL4
G>9!64
3,9ÜãI?,>H#<ÆÀN±Õ.ÒÑ>¾äN·/Kç~dilcNóÊÑ=à =îí/
K,:NÒ½:.4ÔÚNè68(4áº~ñöăØŠ
NîíÊ:/Kç~dilc>óÊÑ<_XPjÁNÖÛ/K,:=®ˆ.4/<M5y$@s
éÑ<ç~…9!KbgRhZPj?…Nej[jËûu:ç~—9!KSWj^jËûu>Ċ
ûu=…*8â$K,:'ä9!J…ƒ =HJ3>ç~Å­Nà =‡«ä9!K,:N
ê„.4Ĉ™ ¦nĉwÑ=?ej[jËûu> QagTlheg'!K|HJGć"bg
RhZPjñ¢w?8BCÃç~9!J,L'v"ñ¢w?8bgRhZPj:”Ý>©"ç~
NÐ/K,:'µI&:<64Ĉ™Ċ‘ĉ<2mæ=rÂpä9!64ç~Å­N¯
NÍ"4…îí9?rä:<64&Nߌ=ùAK<I@¯
>°Á
>°Á9?ç~—9!KSWj
^jË=?){ąN‰$8%I0ç~—:?㝀ª.8"<"ej[jËûu={ąN‰$8
"K4Fç~—å÷>›¹Ñ<Å­?²<ML8"<",:'!+ILKŸā,>°Á=›7)
…îí9?3>•kç~YfU`g?B:O;œ‹10üÈ>E'œ‹/K<;ç~—
å÷>›¹Ñ<Å­?z4L8"K,:'µI&:<68"K
tn>ÓêNФ-1K,:9ÜãI?™ ¦o=×.4ç~dilc>óÊÑîíÁ>ÖÛ=®
a1 'G//
,&E7MVZQ[SO]JaBI-H=D#8M<F9E:_`5?I&
.JY]T]-I 2434 PUZR^[YZH=@*,0IHLAD5"H
>M<F9%E7M_`6!$9<NKEH =@5*,0HC;&X\^WI+")(
_`61
Á‹…—ÊÍk]o No.30 (2009 June) 18
ƒ.3!/<L5
"JÛºšá•=š/J×{glof>ìÆMÓ%Jï
1>Ûºšá•:¿
ÃÇ=҉n†¥. '71>†¥¡9â> PbjUokhj(”)*wr/J…—†¥õ
{—Ç<’…?p€¤Ù<#ö-%É68#K@
,KM¹Â.8†¥? =GIAB½×{9"
I †¥¡= (ã,H<*<J,:9ž#×{MÆ/JglofMàÀÇ=ìÆ/J,:(ˆÖ:
<63!
*)$'(&!#"
¹¦êÐÌõö?
ȁ
Sm<;“*>ħ=îLJ:-K
â:.8> ‚F­7:>®¯F"I
QTY`
æꅶÐ
K¿£Ç<…—†¥¦M­7,:'H
C3ä›9?ÑÕ}¨vç¾
C/C/¸ÈMðE8#J!p‡= :Ü68F
cO`lTYjiZRj
%
pëóêÐ<;“*>Ì(–Ž.
[odo
,KH?1K2
Áx}=&#8FÃ<J ‚M­7ˆÖ¦Fô#! ´~Â
×{glof? ÎÔH>ÊÍu=F#*7'ìÆ-K s9FZVllejQk\Om>÷ò•é
zx9"J (œ*Â#HK8)3!.'.<(H =? í
>¿Ã¦?|*<* C3„ã{MŸ8J4+9 >²½=''LH0”)*×{(‘”.8.C$
µ¼M­68&I
Á¾—Ç=©Š"J^o]M¢J,:?Œñ9"63!
1,9ÎÔH? qå>×{glof^XOm·M¹Â. "J¿˜>¹¦êÐÌ>DM´~ˆÖ<
×{glof>ϙÞÝMßD3Ò³ “°>±Ú×{glof>ìÆ=«ƒ.3 !ø=#*7'
>tØyMË.3( y%@pëóêÐ:doQTYaO_iO_:M1K2Kôè¬Ç'7ôª=
´~ˆÖ<×{glof?
Ô?Nm_i\m'HPm`doQTWO`MÁ«/J…—†¥
M
R5 #%>@-,GB<3!G>@9$2'$M$ "G*F+OPQN):$ 768 G
0"F
M+1G&G(I/J=ED9EH
GKAC "G+;4."G
?L9H$ 768 +OPQN)H3!G>@:5
ԖŒ¡Þãq^u No.30 (2009 June) 19
¬ð;gPeup:carŒ° L-J
.JĖŒ¡°6)4ÌÕ*I'65Ć
ÒÙ9-J.J:÷iruhLĘØ*
I'69µŠ)/
(G9öÏ}揰:æ{ۏ°L‘
Iēé6)4ÝGJA/ȧÔêòƒ5
’â^sfVĉ6ú“€L«µ*I'6
5-JG:̱L‡®)4I'6D·
º(J4IWp^_Rs aos[g
Pou]:ēé̱LþŒ*I÷
iruh:ĘØLø1/ ;Zca
rVrrjs]sEks^gpRr¢²
ĝĔě87ĚŸÉ¹ÀȌ“ÏLôš
ĉ6*I'6"ÝGJ4
HÐ9 Zcar¢²ĝĔNmb; :đ¶Ù8
ôšĉ68Hē鏰:ëÃĤ2:c
arš"Wp^_Rs5í¸(J/°
ÔµÏLxI'6"½G!681//
C':ЯIŒ¡°LÌÕ)4Ô
bc!#&
LA;JR^UVQ` 0*W\`SXP\aT
(-01)Z_aY ,/+1*.2 E%D:3E
-01 E]N^UO[ D@H?:<4Z_aYL
E7MD$:<A9K358>6E7MFE -01
7"DG59ACB7H?I6AC=<4'
êòƒ5:̱ƄLó6*I÷i
ruh:ĂĀLø1/‚€Ù9;vč)/̟á‹6;ϔ#:*8K0carš:ªĚŸ•
©±9š3$÷—!Gjs]sÓĒ~=:…Ÿƒ LÌÕ)˜ĥ9à*»ý ̱Ƅ÷i
ruh L`XOstĘØ)/ ĘØ9µŠ)/ ; 6°*Iˆ; QdpUu:…9Zcar¢²ĝĔN
mbĒ~"…Ÿƒ9 ™*I/C 9FH?@Î÷5I'J" 9F14Wp^_RsŒ(
JI'69FH "Ċ'G8$8H
÷ª¨"ĜċÙ9œž*I'6"çù LÕ/ ¤Ğ!Gß!CGJ/Ð9ªą*>#Í6)4Áiruh;Wp^_Rs:B6;?6M7°,
+ " ™)4†C4Wp^_RsŒ°"Đø*IÐėLÀ)4
HÜ9 ̱L6GI
'6"„ÂIyֆ:÷iruh5IÍ"&GJI-'5¿¬9 LÔêò9Ĉõ)
Ô#4Iêòz: ̱:ƄLăB/-:ëÃêò:âě9F14Ô#4IÑ´5: ̱;ž#$×8I'6A/ 87"Mêò5;˜ĥw9à)/F9êòĉ9Ê>4Ä
ƒ9ª ̱"I'6"½G!681/':F8¾äę…ÿó:ġ³›;Ôêòƒ5È
ó*I ̱Ƅ÷iruh: ™"14†C4­GJID:5HÔÏ¡Þã9
%I÷
iruh:ĕû±LåÙ9à*ëÃ5I
+* )$
!&'"%#(
(G9¿ČgpRq\Os:ĠÅÇďLžñ9üÚ*'65»/8÷iruh`XOsË9ì
"IĄ¥€î:‰ù9µŠ)/*8K0vā: :ï¼9FJ<SplTYš;|:£óš9
¸*I'6"ó8;+5I6ïn_pšnaTYš87|:£óš9í¸)/Ą¥€:Ę
Ø9µŠ)/Ģ˜Ħ¦vģğ/'69'JG:Žè8gpRq\OsĄ¥€;»ýŒ“Ï5H
™mdv £THX No.30 (2009 June) 20
3%][-´¶#96-!:7/4)…š,«_OUXNŠ+,95.*'%%4!:7.
€­«_½‹< ¾][ +œ#¿+ml"% Ž-!:7 .«_•}<¤‰"%¨‡
PVGV˜ >MSBXTPS.Z‚-68«_ºug–’w#9+ .e—-Y©"%
¨‡{7:%08*,
«_ .s›/ADVJV˜·^.¹q=L?Vp*9r
k+aup*9rk*t
,9!+5ƒ7+,'%¾oÀiZ¿†Ÿ¬/OUXN³².
¯“7¼y-…š*9#,;&oÀiZ.?TVF.ˆ*n'% QKAEKS>V<PVG
V˜·^+")( /ADVJV·^=L?Vp.„/z«_}*9Yaup-,9+
12”«_*9+•,}µ<…#9ADVJV¥ª¦+±4)…š,«_OUXNŠ
+,8{9!+<¡")9][†•}<‘š")»ž-~b"%j¢ca°¸¦Wf|h®d
«_OUXN<§\#9
3$@RCKEIXG‘}Œ`«_OUXN ¾oÀx[¿<§\#9
/
’J >‡‹Œƒ~ŽA S[X^[P\VVZ]‘u&Drku+2s=+‘agu+"u=+}
)/il@?(tof`%ypIdn.794qu/e:s0u_M€Š†‚…„$=‰
ˆ SPM_PTY uF1t
il‘axl@?(})/i`%ypsc68*Etzmp`!Gu=
)}-j{ > NTWVU =;5KNTWVUJSP HLuF1t
ilaSPMQRO }B<il79qv`Ch|p
c{32u NTWVU =;5t'wpsc*Eq`I,t.79u=#;e:qbmlaJ
䞔ªíò}o No.30 (2009 June) 21
yrhkr|eaANwnãĝ‰J?] ĪI1\/;Nv~uĂĔNhjqãĝ‰N
Õğ¤O/gzirmJû›=H2]eq|ÏĘJLEH4\/ZEH ) NÕÛنIX
©¡aJ]ûË/STÜƌ»I1]0;^6.gzirkpnMZ\ßçéM“ՏĊ<^];
JI/hjqãĝ‰NÕğ¤Ot{JL]6/AN ) 6ø I1]BWĀv~r”=Hc
sf¡JL]BW/ä¾ÞI1] "" Oµ2ƌaè?]0?L`DÉv~uO.g
zirkpnØ»ÍŽĆŒv~uJ=HÑÿ?]0¬Ħ/ɗº‘¸INƌ¥¨áOø ‹M
Xě=/ÎWHĠÀM.gzirkpnػ͎6˜ÿI1]0
.gzirkpnO}xoĞùJ=HÆXÖå<^H2]6/;^UIN͎×O % ÌĄ
LKNŒ×a–âJ?]XN6SJbKI1\/–âéMĭ½´I1]O@Nƌ×6å2[^];
JOĨ³M±L5EB0ˆŸġèM¾’=B % O©Möĝ‰aİF=5¿B@/;^6“Õ
Ċ<^]İÒĥN—ºI/¹Ê5[ë[^H2]ƌv~uĮ%-(*"+ "$'!$#% ,(+$!"/
IJ²„įNıÒĥMê¶?]ƨNƌµ´¦”aä>]Z3MČċ<^H2]BW/Ĩ³M½´
ă8.gzirkpnØ»a͎?];J6˜ÿJLEB0Év~uOäúþ÷QNĜå6˜ÿ
I1\/¬Ħ IJ²„Mð=BZ3M/äúþ÷M4:].gzirkpnNĭ½´ÍŽM…æI
WH¾’=B 0
ƒĖNČċ×Iå2]c|h|¤ĝ‰O/XD_bgzirmMģ[^]XNIOL20;^aŒ
ĊĤ»ŠĐ¤I1]sr~wl|¤J?^P/2`Y] #"! ƌĄù6Ďä?]0¬ĦÉČċ×M
¤G2Hġè<^B O/A^ĂĔO© " NûËSTÜƌI1\/;;M '& NĊĤ
Œaݯ?];JI¨7Lƌ¥¨að? #"! ƌĄùJ=HÑÿ?]0 OƒĖN %
JœÐ/İÒĥNŒĊĤ»ŠĐ¤NĀħMZ\ƨNƌµ´¦”aä>]BW/¹ÊĄùMÓRÎW
HìÅĢNĊĤŒÝ¯I•‚úþNĆŒÌĄ6˜ÿI1];JXð<^B IJ™„0
ôý[6Æĕîó?];JM¾’=BÇÑ°©ĆŒv~uNďâéLČċ×MZ\/ġè˜ÿL
ƌv~uNñĪOīēéM¥¨=/ä7H2]äÞčÂN†IĒ;]šñdwra˜ĉ”?]Ã
Ĉƌv~uüNġèM¾’=B0ġè=Bƌv~uüO/úþ£ĬÙMړ?]C:I/­Ä
MúþāaėĚ=Hä7H2]úþMđą?];J6˜ÿI1\/?9MIXäÞªĩ¢íòMĜå˜
ÿL¬å»a¿EH2]0;NZ3M/”ªa¤ïJ=Bƌv~u©aõ®MČċ€ġè?];
JI/äÞªĩ¢íò6‚ÔMęV;J6¨2MÈ·<^];J5[/ˆ¸X§ñ§ÐLÑÿa¿FĆ
Œv~uNġèaĠ¼ćEH28‡«I1]0
Áà
1. Akwasi Minta et al., J. Biol. Chem., 264, 8171-8178 (1989).
2. Tetsuo Miura et al., J. Am. Chem. Soc., 125, 8666-8671 (2003).
3. Kumi Tanaka et al., J. Am. Chem. Soc., 123, 2530-2536 (2001).
4. Naoki Umezawa et al., Angew. Chem. Int. Ed., 38, 2899-2901 (1999).
5. Ken-ichi Setsukinai et al., J. Biol. Chem., 278, 3170-3175 (2003).
6. Tasuku Ueno et al. J. Am. Chem. Soc., 128, 10640-10641 (2006).
7. Suguru Kenmoku et al., J. Am. Chem. Soc., 129, 7313-7318 (2007).
8. Yuuta Fujikawa et al., J. Am. Chem. Soc., 130, 14533-14543 (2008).
No.30 (2009 June) 22
9. Yasuteru Urano et al., J. Am. Chem. Soc., 127, 4888-4894 (2005).
10. Mako Kamiya et al., J. Am. Chem. Soc., 129, 3918-3929 (2007).
11. Tomonori Kobayashi et al., J. Am. Chem. Soc.,129, 6696-6697 (2007).
12. , , 381, 44-50 (2002).
13. , 37, 370-374 (2005).
14. , 57, 699-706 (2006).
15. , 61(9), 23-27 (2006).
¾ul‚ÊÐJ8N No.30 (2009 June) 23
˜UÀ jĂ (ă
TŠ~‚~‚û46:D¾u΂ 46:D¾u΂†Ÿ Oî”m{ëÏ 4 Ž ¸‰ÊЅ
[email protected]
‘¾ul‚ÊÐJ8Nì¢ÙX2N=N
yÒ­[,ÿ’&(–íâ!
»xÍTŠ~‚~‚û46:D¾u΂¸‰_¬ ›šˆQØÝcHLöl
õÖĂ/=N7ă“Ó­ÞĞ)46:DùÄ,ç
(!‡¨ÆᏓ
¿qÞô\€/FHGNº„õÖåb-EN5L146:D
“¿,ç
Û!WvÃØÝCN.Nªe46:D™Ãi¤ÈégY
zĀØÝ,`¿ä¹×46:Dì¢,**ÙXÿ!
Integrated Barcode Chips for Rapid, Multiplexed Analysis of Protein in Microliter Quantities of Blood
R. Fan, O. Vermesh, A. Srivastava, B. K. H. Yen, L. Qin, H. Ahmad, G. A. Kwong, C. C. Liu, J. Gould, L.
Hood, J. R. Heath, Nat. Biotechnol., 26, 1373-1378 (2008).
§ì¢C-0K³ñ,¿>-6INB9;]26;ā–‘ÃØÝCN.Nf
€ªe²,ËÑ!ÕÜæSº„8L?0ïĂÃCN.Nf€ăf±ø
~sP
(æSø,µ„)Ô¥ÆÃê£ç+*!a
hÑàÕÜhÑàºÁ™o (Prostate Specific Antigen; PSA) n‹MՋß•Ü@;
Ú¯”3=<;KAL (Human Chorionic Gonadotropin; hGC) æS·‘Vó!œp
æ´S8L?0ïRƒ„ɦúd½)°#'*!!&CN.
Nf€}¡(r¦}¡ª^,d½)$r«÷è(!
w 1(A)ãÜ'ùÄ IBBC
(Integrated Blood Barcode Chip),Ì
!æ´SÇÆC
N.Nf€Z|þŒ}
ü¹x!!8
L?0ï®òþŒ~
ðæ¼%Åæ¼Zweifach-Fung
k©&(ÇÆCN.Nf€,
t"涗ffý)q
Þ*C-0K³ñ,`
«f^qµ»C6G No.30 (2009 June) 24
HX¨'"&Ì¥…WK&³±@G0GWp+˜V(€Î
'"
@G0GWpu(‡P+ètzSæ DEAL (DNA-Encoded Antibody Library) ;G3
G:¡%')+ޅ"éh 1A חêDEAL ¡mº‡P+HzSæ(#
m‹@G0GWpW ß+Hz¤r(
`Åh 1(B)Z¼È¯ƒÃ&‰_
Ì¢4E>BK PSA % 11 º4.90.EW C?B¤rÁ–12 º@G0
GWp
äx)WãF˜V(
W'"h 1(C)Ð 22 MZ¼È¯ƒ
ÃéP01-P11ê%L¯ƒÃéB01-B11êÌ¢4E>BK PSA W C?B+¤rÁ–
L¯ƒÃ4E>B!, PSA ¶Ó)uZ¼È¯ƒÃ4E>B
èW (
W'"& IBBC %(¤rÁ–6E<1֘V¡
ž¬)( ELISA (Enzyme-Linked ImmunoSorbent Assay)¡bš˜V>D=-.B%„
z
~&)”˜V¡‘¬‚
·)""¤r€ÎÌ¢4E>Bß
‹ μL /G7Gäxßv•±¿Q¯Ñ¡¬
’})(jd
'"
Stimulation of Tumor Growth and Angiogenesis by Low Concentrations of RGD-Mimetic Integrin
Inhibitor
A. R. Reynolds, I. R. Hart, A. R. Watson, J. C. Welti, R. G. Silva, S. D. Robinson, G. D. Violante, M.
Gourlaouen, M. Salih, M. C. Jones, D. T. Jones, G. Saunders, V. Kostourou, F. P. Sierra, J. C. Norman, G. C.
Tucker, K. M. H. Dilke, Nat. Med., 15, 392-400 (2009).
mi{¯Ì½T²ÀÄlœgp(Vascular endothelial growth factor; VEGF) Ý\°©
'¯Ì½Ž«+Ôw¯Ø¸+RÜ""ÀĊ´gp(.E8
2AE$̽Ž«£áJ'.E82AEâs[ (Cliengitide) ¯Ÿ®Ë
ÉyÒç
Í*)(K'"
&Cliengitide ÆÇ­uHrŸ
®]–+~"
N¯ÊoÁ–
~&)",”ÕŒè§z¯
F
F
F
Ÿ®]–
¶Ó)( Cliengtide%OWpâs[ S36578 O§zÛ¯…à+
RÜ"+ÏV"&)&áJ(6E<1ÖVEGF
C5>6G6E<1Ö (VEGFR2)v3 .E82AE(v3)6E<1ÖA4.1AE2+Ôw
( RabA4 +ˆ"h 2(A)O§z (2 nM) S36578 Uª%( VEGFR2 % v3
ÀÄeÚ
§Â]–+¶Ó"VEGF %'ÀÄ+Y¦(“Y¦$Ù
VEGFR2 ÀÄeÚ°©ß
cI"&)+O§z S36578 Uª(
“UªkaÙncI(
¶Ó)"›O§z S36578
Ž«Ì½™¾J(|å+
¶Ó"éh 2Bê"À
Ä+ VEGF Y¦(̽
Ž«
¶Ó)"VEGF Y¦
ÀÄ+è§z(50 μM) S36578 Uª(̽Ž« VEGF
“Y¦ÀÄb¹z"†(
`ÅHO§z
ՂxâæR>V No.30 (2009 June) 25
S36578 lÔ+VEGF sÍïö(*ËÞāé³ÕĂ.,+n
*$¶
N@QK2;/ÖݦĜY+w¾/ãċ$Ýñô S36578 /Å
ΛlÔ-1 mg/mL ^XݦĜ/©r”_Λ(0.1 mg/mL)lÔ
Š~9TASVQÇЦĜ™eĔ,+ãċ,$,)ò¾
U
U
U
(*_ΛĠ’u(*(1) Rab4A Ë¢x Ī@V>º­đī(2) RabA4 (+ VEGFR2
(! v3 ïöĒ#Îó († 2 A)(3) VEGF (+³ÕāéÄêeĔ († 2 B)(4) Ý
¦ĜȖ († 2 C),+WēM4C<L/®ƒ$‘ġÈÜþÐ
ù׫¯(*݁ĒþÐΛÆè_Λݣx+¥¡,$
•½ß݁ĒþÐΛ/‡x+¨ă+¼²Ÿć+
'
,$0
High-Content Single-Cell Drug Screening with Phosphospecific Flow Cytometry
P. O. Krutzik, J. M. Crane, M. R. Clutter, G. P. Nolan, Nat. Chem. Biol., 4, 132-142 (2008).
ѐÚÛïöѐ>TE6ďPTĘxėíĪ5BV=īˢ٘\Ĕ+
‰€,$&,)ėíĠ’uÚÛÈÜþ+¹œ$
Ñѐėí(!ѐïöĢ…%aÖ+Ġ’uvaÖ/„Ė+XĤ˜
·Ö$,)ėíĠ’u;6PVCT7ìĝÞ'Â&ęć
105 gz"hĄþÐëąėíïög`Œ—.+ĉdĂ.,¶ðß°g
þÐøšĊĨ$.,$WÆ;6PVCT7[ëąėí(+Ġ’÷ĉdĂ.
,$ëąėíĉdúŽò¾ž),þП'Õ`k·w.
*$0$ëąėí(+ĉdüµĞĎěŸć*$&(*w
ÒßþЬî/àßïö/qÖD1;QVI?A;6PVCT7ìo¸,
$»č±GSV:1AMAPVĪFCMīÑ¢/qÖ+µŒåïö
>TE6ďË¢/ĉdD1;QVI?AïöJV;;6PVCT7ì/‘Ó$
† 3(A)§Ø/äá†ĪPhosphoflowī*$p&þu(*àß>TE6ď
Ë¢/\Ĕ$ÆþuhĄx~Ð/lÔàß>TE6ď” ÿifĦª`
ĪĆ°>TE6ď>V8?AŠ~fĦ+ÿiÿiÊĜ/‹+¶ 15 å$|
÷ī/aÖ¿û$¶ FCM Àm/Ă$t‰ª`Λ¿ûµ
ĞEOMV>V/¶ĕx*23;>THS?Aò¾Ĥ˜ĩáğ/ž$
ĪCytometry A, 55, 61-70ī
$235 gx~Ð Phosphoflow (+ˆħïök Stat1Stat5p38 Ë¢Ġ’÷ÀĈ
/Ă$† 3(B)Z 12 gF?AþÐò¾/ä$c
HHT
p38 ·wĠ’uStriatin E Stat1Stat5p38 j·wĠ’u+n
*$
(W›Ìž),+hĄþФ‰ĚŒĩ;QVI?AxŸć¨ă
*$
)ýõ)t‰ãç FCBĪFluorescent Cell BarcodeīÉ († 3(C), Nat. Methods, 3,
361-368) Phosphoflow /Ā~ Phosphoflow/FCB É/p]ˆħïö Ö$ѐ
ñô
)yWp]ˆħïö/ž+&ÏģëąaÁŸĥW´}ïö
U
U
ѐ{“`ÞÓ*,)”+ÿifĦª`/bÖ+ëą+
…WO`‰Œ8/; No.30 (2009 June) 26
‚a‘•“(x
L%S–'Phosphoflow "$]‹£
¤bNw(FCB }"$]‹‘•c%¤bNw(ŠŸ%
<X~ag#
&%i[¨¡ˆU=Y 3(D)Phosphoflow/FCB }—˜#kRu
M?Z©‘•«B ‘•T ‘•Q„{ƒ‘•V&%¬K Stat1 c% STRPN ¤
bNw(~a$B ‘•K Stat1 cdD_ˆ¤bNw\^%
ŠŸ&<qCD4+ T ‘•K Stat1 cJ¤bNw(>)
’w+,./:4901nTh!ªE¦
%’wsf™”#
STRPN ¤bNw(FA867yžIM?Z©‘•Ž§@’wg#
&
"Phosphoflow/FCB }(C†%Gœš]‹/:3- "‡‹
‘•“(VM?Z©‘•c%¤bNw(€¥Bz(›2*.7;501
~a%
vo‚¢)vj}(1)š IC50 H(|
a%(2)mPFš(<r~a%!S–pM?Z©‘•(C†š
l}te&
No.30 (2009 June) 27
$ %
"#
! 3 [email protected]
²Ã9Ĥ]%1ioêÚî¦TÂÁ¼»G§Ñ*s·ÎSÑ«¾ ¯¤ŒÂ¨Í®Àª³µ©È
·¥lÄ..1^Om1io@ ‚&1io˜Â¾ƒŸFD¤.k`X/FDÃ<C
4ÃÊÀioх¼¾¬ÍÈ·¥/™ GTP z#ÚìãՏĕ
/e[¤w~$L­Ì€d:?í‘
n À 6 7 ° œ ¶ ¤ ² Ï Ì Ã | ˆ ; ¢ Ñ B ª prenyltransferase à farnesyltransferase À type-I
geranylgeranyltransferase ÄA®ÒÃRf—vÀ¶¾Vg´Ï¾©È·¥lÃioIJÏÌý×
vÂËÎ|ˆ;¢Ñya¶¾S¶¤·©®Òà 90%Â-c®†´Ï¾©Î K-Ras4B Ã|ˆ
;¢ÃÉÑNfž2·Î prenyltransferase dual ž2Úe¿·¥
'ĤÚìãՏÃQ’-Âhg¶»H»ÁÙÕèîàìÖUše¤RNA ¬±ÎèæáÕêÔ
ÛÞÃH»Á#?y¤/‹ŽÂËÎØÖßé
“Ã_S8ÇIýѳx¶È·¥
A New Screening Assay for Allosteric Inhibitors of cSrc
J. R. Simard, S. Klüter, C. Grütter, M. Getlik, M. Rabiller, H. B. Rode, D. Rauh, Nat. Chem. Biol., 5,
394-397 (2009)
kinase ž2Ä i) ATP Àr#¿¯¤£°0´Ï» kinase domain à hinge region Âz#·Î type I À¤
ii) hinge region ¬ËŨÈÍ0´Ï¾©Á© allosteric site Âz#¶¾ kinase ÑW>)·Πtype II À
III ¡¿¯È·¥©¸ÏÃ+#ʤ.¯Á library ­ÌÃ#ZÉÂÄâÓÙéîåÜÝÙÕèîàì
ÖïHTSð®Nf¿Ä¨ÍÈ·®¤#ZÃRfÚìãՏÂ3¶¾Ãz#áÂÄ HTS Ĕ¶¾©
ȹҥ²²¿x·ÎGĤkinase ž2à type Ñ¡¿¯ÎH¶©ÙÕèîàìÖњe¶»À©ª
G¿·¥
kinase ÃW>)Ä(Ã"qÂj·ËªÂ active loop ®©¾ type II/III ®z#·Î allosteric site Ñ
K¶¤ATP ®z#¿¯Îç×ÜÝÑÍ·ÃÂ3¶¾ï( 1 a b"ð¤W>)¿Ä active loop ® ATP
Ãz#ў2¿¯Î˪Á–{Ñ!ÎJÐͤallosteric site ÑE·Îp›Ñ]ɶȷï( 1 a 5ð¥
s}ÌIJà active loop ÃQ’-Âh
g¶¤kinase ý¿¨Î cSrc Â\,=
u)Äåëîäà acrylodan Ñ4
¶» cSrc Ñ_©¾¤W>)à cSrc Âz#
·Î type I ÀW>)Âz#·Î type
II/III Ñ¿¯Î­ÑŠÉȶ»¥ž2
ÃÁ©M¿Ã aclyrodan-cSrc Ľ
ÃeP.Ñj¶È·ï( 1 c 475 À 505
nm𥺲¤type II/III Þ2Ñ_
´¹ÎÀ½ÃeP.®ÆÇt¶°Y
%#'
& !" % $ ') % '(
No.30 (2009 June) 28
=ºÄ®µÉÈ<ºÄ«type I É ;Øq¹½À1)ÅÊ«475 nm Ét`6Éί³‡ºµj=º«
505 nm Ét`6³ 510 nm ÌßèãºÏ¼¬·ÉÒ¯È active loop Éa–4#È®ˆêðóéÉo
3±ÒËIÈ4#³p»Õ·ÆØqºÄ«type I Æ type II/III Ø$³Å´Õ·ÆØwºÄ®Ï¼¬
© ÏÀ«y…Ó³žtºÀ-É assay {ØqºÄ«p38 kinase È nM ƨ® affinitiy ØMà type III
;É scaffold ƺÄ(ÔÖÓÖÄ®Õ pyrazolourea Ø^Æ¼Õ 4 ÃÉ#)mØ)Jº«cSrc È<ºÄ
ÃÉ#)mÉ IC50 ³| 30~65 M ÉhIØwº«type II/II Æ*» binder ƺÄc†¼Õ·Æ؊ºÄ
®Ï¼¬¹ÓÈ«¾ÖÓ#)mØq®Ä cSrc ÆÉYØJº«typIII ;Æ*»)b@Å­Õ·ÆÑ
wºÄ±Ô«-žtºÀáÜíóåñݳTº® tool ƺÄ["Å­Õ·ÆØwºÄ®Ï¼¬
Synthesis of Activated Pyrimidine Ribonucleotides in Prebiotically Plausible Conditions
M. W. Powner, B. Gerland, J. D. Sutherland, Nature, 459, 239-242 (2009)
íëæÜïÛâ䳛)ºÄ RNA ³BJ¹ÖÕ·ÆÊ:Ž
¹ÖĴϺÀ³«¾ÖØaJ¼ÕÀÐÉhI#¹ÖÀçíì
àñíëæÜïÛâä 1 ÉBJÊWӲȹÖĮϽÙź
À¬·ÉRÊ«·ÖÏÅȄ°ÓÖÄ´À~‘ô£õÆ*»
8§Øq®Ä«ÉŸØ~rºÄhI#¹Ö
ÀçíìàñæÜïâäØvµ«¨"nÇîóãôõØtŠº
ÀÆ®¯ÑÉż¬
1 ÊçíìàñæÜïÛßä 2 Éíñš#ÈÒÂÄ«2 Êçíì
àñ 3 Æíëóá 4 ɂ)ÈÒÂÄp»Õ·Æș®ÊÇ®
Ƅ°ÓÖÄ®ÀÉÊ«3 Æ 4 ³)J¹ÖÕÆ®¯:ÈÒÂ
ÄPM¹ÖÄ´ÀÀÐżô£É~‘õ¬º²ºÇ³Ó«2 Ø
)J¼ÕÈ­ÀÔ«3 É N-1 ɤ[¢8<ɤ>/#±
ÒËfkiÅ&G³‚)ÒÔÑ!fŒ³7ÏÖÕÆ®
ÂÀ·Æ³«·É~‘É,¦ÆÇÂĮϺÀ¬¾·Å«y…
ÓÊ.ɁÅw¼TÀÇ~‘ØN+ºÄ«¾Ö¿ÖɜÆÇ՟ 11 ²Ó 12«13 ÈîÄÉ&G\
É_Ø‰®«¾ÖÓɟØ~ÄhI#¹ÖÀíëæÜïïÛâäØ)J¼Õ·ÆÈJ
ºÏºÀ¬8 Æ
10 ÈÒÕ 11 É)JÊ«A20Åɂ)³€uÇKgÅ­ÂÀÉÈ<ºÄ«I\
ÅEÕÀÐÈ
lcíñš2Øq®Õ·ÆÅ>80%Å 11 ØEÕ·ÆÈJ
ºÏºÀ¬ÏÀ«·É&GÅ 8 ؗȼշ
ÆÅ 3 É%SÆÇÕ urea 6 ³EÓÖÕ·Æ؊ºÄ®Ï¼¬dÈ«9 Æ 11 ²ÓÊ 4 ÃÉsI³BJ¹Ö
Õ³«lyxose«xylose ʤ?È'n³µ«¹ÓÈíñš29/ŝXŸQƒºÄ±µÆz³žoºÀ
BÌÆ4O¹ÖĺϮ arabinose 12 Æ ribose ³ major ÅpJ¹Öϼ³«ribose Ê·É­ÆÉíñ
š#³p»Ç®ÀÐÈ«]ƺĜÆÇ՟ 12 ³pJmÆÇÔϼ¬¾ÉD«12 ²ÓËlcíñ
š2Øq®Ä«&GÉ pH ÉVØL°Õ·ÆÅ anhyrdousnucleoside13 ب'nÅEշƳŴ«13 ²Ó
1 ÌÉíñš#ȱ®ÄÊ 5’É 1 }ÚîÞóîÈuÈp»ÕÉÅÊǵ«3’É 2 }ÚîÞóîØ
ºÄp»Õ·ÆØYa–²Ó 5’Éfš0³ 3ªÆe”ºÄxuÇ"]ÈÒÕÑÉƺ«&GÉ
kiÅѾÉ"]³C¥ºÄ®ÕƕÍĮϼ¬¾ºÄ«3’Éíñš0ɓØ~rºÄ«hI#¹
ÖÀçíìàñæÜïÛâäÉ)JؘJºÏºÀ¬:¡È¸‹ÈÇÓÖÀU³5®ÉÅÊòòòÆH®Ï¼³«
íñš2ÊZDÉæÜïÛâäBJÈ×ÖÕÁ¶Åǵ«œÆÇÕ&GØF¼ÕmÆºÄh’ºÄ®
No.30 (2009 June) 29
‰zŽyRNi˜PNS(‰¤–*&‰¤¡}• —™€£“{£y+t–…—¡}•7§k‡
’ RNA 
;†¥Ž—€•”8}¡}•g?“‡Žz
Sialylated Multivalent Antigens Engage CD22 in trans and Inhibit B Cell Activation
A. H. Courtney, E. B. Puffer, J. K. Pontrello, Z.-Q. Yang, L. L. Kiessling, Proc. Natl. Acad. Sci. USA, 106,
2500-2505 (2009)
x B Y^=¹­³®
A
B
»¼BCR; B cell antigen
receptor½˜ B Y^§I
9‰¤ BCR ¬«°¸
§Y^›~¤4
§
>

acid-binding
y
sialic
Ig-lectin
3 A: polymer B:
Polymer 1-3 2+
[Ca ] (Siglec) — ² ¨ µ · » —
‘— CD22 ˜ BCR ¬
«°¸§q,‰¤
-”V¢¥’£yCD22 ” BCR —0&–¡’ BCR ¬«°¸—I9§<~¤…”A¢€”•’
|‰z@yCD22 — ligand §>‘X®º±ªi” CD22 !Y^av“—UQ“{¤ cis
interaction ƒ” BCR ”—0&“‚•|ŽŸ–yB Y^—I9Pˆ¤…”'"†¥’|‰z
‡€‡yŒ¥”˜/MT– CD22 ”
— B Y^—av—X®º±ªi”—UQ“{¤ trans
interaction ”yŒ…€¢Pˆ¤¬«°¸—3w˜“CB•“‡Žz……“Z‰¤g?˜ B Y^—
I9—5–„¤ CD22 — cis ” trans interaction —$Fp§A¢€–‡Žg?“‰z
x % 3 A –W‰¡}–yBCR antigen — DNP —ž— polymer 1yCD22 ligand —ž— polymer 2 ¡š
antigen ” ligand §[ž
¦‹Ž polymer 3 —‘— polymer §Q|’ B Y^—I9—O6“{¤[Ca2+]
—)—c.§`|‡Žz% 3 B –W‰¡}–yBCR —=—ž§>‘ 1 ˜ BCR ”\
Y^av—X®º±ªi”\
‡yCD22 ˜ B
‡‰z¡’ 1 §Q†‹Ž”‚˜yCD22  BCR €¢su†¥Ž2§
¤ŽŸ– B Y^I9—<–nb“{¤0&j…¢Š–I9§l‡‰zG– 2 ˜ BCR —
antigen §>Ž•|ŽŸ– B Y^—I9§l‡•|”|}:k£—\F§W‡‡Žz3 –‘|’˜
_#K|…”–yantigen ” ligand — 2 ‘§>‘ŽŸ– 1 ” 2 —Q—o—I9§W‰€”]~¢¥‰
yB Y^—I9§l‡•|”|}\F§W‡‰z…¥˜ 2 — BCR — antigen L|ŽŸ– B Y^
—I9l†¥•|”|}\F–/‡’y3 —\F˜ antigen ¡š ligand —Œ¥¥eh†¥’
CD22 ” BCR —0&§‡‰z‡€‡y…¥˜–‘— polymer –Œ¥¥— antigen ” ligand §
D‡’|¤ŽŸ“{¤”]~¢¥‰y1 ” 2 —Q˜ B Y^—I9§l‰¤”|}\F€¢y3 ˜
trans interaction “ BCR ” CD22 –Q‡’0&§1‚j…‡yB Y^—I9§<‰¤…”§W‡
‡ŽzŽy1 ” 3 ˜ BCR — antigen §>‘ŽŸ– B Y^I9— BCR signaling —EHr˜l†
¥‰zŒ…“ytrans interaction — B Y^I9—<§dY–‰¤ŽŸyBCR —·ºm¯¶©º—
kinase “{¤ Lyn ”y†¢–Œ—J— SykyPLC2 ·ºm—¹´¸§fœŽ\FyLyn €¢J— Syky
PLC2 —I9§<‰¤…”§A¢€–‡‡Žz
No.30 (2009 June) 30
—
—
—
R‡— ˆ— ݼÁ«³— ¾ž£Þ—
PmWm*,— aNE0,jp<— W,ujpm— 'ƒnß2—
[email protected]
¥´3µ™a!,jpÙÐÜ´…Ds´V
ŕ£‚³9†z§¸¨š_#™kµPmWm
*,´l;CA´°™[rvÐÛÒɉ;³¿ÂxÐÛÒɉtŠ×ÕÏÜÖ´„}±Vw€™
\³xÐÛÒɉ¢Vw¨Â]:°^{¤×ÕÏÜÖ³t¹Šº=Y´jp³BÄ­¯ Á¸¨š—
¥Ã¸°µ™xÐÛÒɉtŠ×ÕÏÜÖ´„}Y±§¯µ™³rv³hf´xÐÛÒɉÅ4e_¦
©™d”Z8qÅc¯>™“§«¼´Å×ÕÏÜÖ³T;¨Â=Y¢cÀ§«¢™‹
2[rvÐÛÒɉ;³¿­¯;§«xÐÛÒɉÅ×ÕÏÜÖ³t¹Šº=Y¢‘e¦Ã™U›²
xÐÛÒɉtŠ×ÕÏÜÖÅ5;¨Â¹¢²¦Ã¯¸¨š¥´¿ž²=Y´e/³¿Á™¥Ã¸°Li
²´)xÐÛÒɉ´TQ½™Vw´G³’¨Âjp¢Žº¥±³Ÿ™.H³xÐÛÒÉ
‰tŠ×ÕÏÜÖń}°£Â«»™bS7c¼gƳ|ÄÃÂ¥±¢K6¦Ã¸¨š—
Mo°µ™[rvÐÛÒɉ;³¿­¯xÐÛÒɉÅ;§™×ÕÏÜÖ·´t¹Š¹Å-F§¯
…D³®¯˜$s¦©¯«¬£¸¨š—
A Synthetic Biology Approach to the Constitution of Membrane Proteins in Semi-Synthetic Minimal
Cells
Y. Kuruma, P. Stano, T. Ueda, P.L. Luisi, Biochim. Biophys. Acta, 1788, 567-574 (2009).
×ÕÏÜÖµª´5]™8‰¡À0rvÅ5;¨ÂNE±§¯Jc~¦Ã¯ Á™rv´?®U›²
Vw™Ÿ¶ÐÛÒɉ;wqÅ×ÕÏÜÖ³?¦©Âjp¢-F¦Ã¯¸¨šM…D°µ™×ÕÏ
ÜÖ³y1&XwÅ?«©Â¥±Åh@§™×ÕÏÜ
Öx´T;;Å×ÕÏÜ֏°;¨Â«»³™
–¡ÀÔÍÓÇÑÌېÅ;¨ÂxÐÛÒɉ
ř[rvÐÛÒɉ;³¿­¯×ÕÏÜ֏³
t¹Šº¥±Å¹¯¸¨Ý"1ޚ¥Ã¸°³¼[
rvÐÛÒɉ;Åc¯xÐÛÒɉtŠ×ÕÏ
ÜÖÅ5;§™xÐÛÒɉÅVw¦©Â¥±³;
§«$
µ+#§¸¨¢™M…D°µ™Ê×ÎÚÜ
Ø-3-×ې±ÈËØCoA¡À×ÏÔÍÓÇÑÌېÅ
; ¨  x Ð Û Ò É ‰ ° œ  GPAT
Ýsn-glycerol-3-phosphate acyltransferaseÞ±×ÏÔÍÓ
ÇÑÌې±ÈËØCoA¡ÀÔÍÓÇÑÌېÅ;
¨  x Ð Û Ò É ‰ ° œ  LPAAT Ý lysophosphatidic
acid acyltransferaseÞÅt¹ŠÆ¬×ÕÏÜÖś
´×ÕÏÜÖ³t¹Š¹™`%OŌ°(I
No.30 (2009 June) 31
Ÿ¨®–°¡š’2fŽ­tÍâÖļÉãÆâÉÝà¬Wž¢¨’™·@lV8T©•¹ØË
×¾ÎÊⅼ!8¡¹ª¬8Ÿ¨–°¡“}¡¹w<­tÍâÖļßÙÌãÛ¬m±€²
ªš
r¬«¹ª©’¶¸w‰«Kr¼9Ÿ¤ßÙÌãۚ8©›¹¤³’J”«5WšC3žº°
¡“°¤’ßÙÌãÛ¼I8¡¹s­fŽ¬¶¦¨’tÍâÖÄ­!8†’!8Ÿ¤tÍâÖÄ­ßÙ
ÌãÛ¯­†’tÍâÖÄ­O7†š[«¹ªµ’!8?¬ßÙÌãۚ,'¡¹ª©tÍâÖ
Ä­O7š‘œ«¹ª–¦¤R´e%žº¨˜¸’‹1¬u$P–nG©•¹“
Cell-free Synthesis of the Torque-Generating Membrane Proteins, PomA and PomB, of the Na+-driven
Flagellar Motor in Vibrio alginolyticus
H. Terashima, R.A. Yoshizumi, S. Kojima, M. Homma, J. Biochem., 144, 635-642 (2008).
1(`¬kŸ¤~=©®’ÉãÆâ
ÉÝà¬}¡¹2fŽ­tÍâ
ÖļßÙÌãÛ¬m±€½©–°Ÿ
¤š’D~=©®’aWŸ¨1§­
Kr¼-U¡¹2fŽ­tÍâÖļ
SjqÍâÖÄ!8Ÿ’­ßÙÌ
ãÛ¬m±€²ª¼{±¨–°¡“Í
ãÇÏÒªŸ¨–¹tÍâÖÄ®Vibrio
alginolyticusXE­PomAªPomB©•¸’
4+­PomAª2+­PomBšt
2 1>4, ! PomA # PomB $ ;70?8
"$@Ni-NTA (+=?/*:8' !5
:,.9>$6=23)>-A SynBFTB5=?/
<?WBE1E2B@%&A
©w!¼28¡¹ª©’MÜã
Íã¼I8¡¹ªšb·º¨–°¡“~=©®’ßÙÌãÛ,'©SjqÍâÖÄ^U¬¶¦¨2
fŽ­tÍâÖļ"?¬!8¡¹ª©’p¼¬^Už¢¹ª¬^UŸ¤tÍâÖÄšßÙÌ
ãÛt¬m±€°º’pšaWŸ¨–¹ª¼e%¡¹-Ñã͚ežº¨–°¡“_¬
®’PomB¬his6Íż
Ÿ¤´­¼^UŸ’Ni-NTA¿ÃáãËÂÞÛ¼‚¡ª©’Íż
Ÿ¨–«
–PomAšPomBª" Y©Hžº¹ªšežº¨–°¡ä&2å“L6«š·ßÙÌãÛt¬m±€
°º¤tÍâÖÄšKr¡¹ª®d|©›«™¦¤ª­ª©•¸’£­R¬§–¨®4­^0šB
°º°¡š’aW¡¹w<­tÍâÖļKr¡¹2©ßÙÌãÛt¬m±€²ª®’w!­
IƒxFµKrzi­AW«Ðãଫ¹ªo—·º°¡“°¤’~=©®’Dg©kŸ¤tÍâ
ÖÄ­ßÙÌãÛ¯­m±€±)¬´’ZŒO7,'©­SjqÍâÖÄ!8¬¶¹tÍâÖ
Ä!8µ’!8Ÿ¤tÍâÖÄ­
Q’aW­Hy´v»º¨˜¸’¥·´u$P–.©
¡“
Liposomes-Mediated Delivery of Pro-Apoptotic Therapeutic Membrane Proteins
L. Liguori, B. Marques, A.V. Mendez, R. Rothe, J. L. Lenormand, J. Control. Release, 126, 217-227 (2008).
D~=®’SjqÍâÖÄ!8Ÿ¤tÍâÖļßÙÌãÛ¬m±€±’jq¬ÑßÕß㟨t
ÍâÖļWž¢¹ª©’]i­N\¬W¡¹ª¼`:Ÿ¤ch¼->Ÿ¨–°¡“_¬®’
ÚÒÈâÓß¿­tÍâÖÄ­„7#š¿ÙÒãÉË­‡*Rª«¹ª™·’ÚÒÈâÓß¿­)t¬,
'¡¹tÍâÖÄ©•¸’ÚÒÈâÓß¿)t™·­ÉÒÄáÛC;¬/¡¹Š,7ˆÀÁâÎÝÔ
No.30 (2009 June) 32
µ¹ Voltage-dependent anionic channel»VDACº„–¯§¸Ÿ
d?vqoA†°§œ·¨´–‡
X†!{‘X£·
«šbƒq‘Bak“´¯¢¸±†T‹c‹oLSW†¦´ª´
¸z‚–¯§¸Ÿ“_M{‘x„“]‹‚rŠ{p
=a4ƒˆo:†HSW£·«šb0†Ž€‚VDAC
tŽ‰Bak“0zo´¯¢¸±!ƒ0{‘x„ƒ…
u6‡‹“T‹c”~´¯¢¸±tŽ‰V“†T‹c
”~´¯¢¸±“`Y{‘x„†0z}x„vy’‚rŠ
{p9†o³R#'hf-“Kr‘x„ƒo.*‡GE
uX£·«šbTc´¯¢¸±“QY{‘x„†0z‚r
Š{p
B†oQY*‡X£·«šbTc´¯¢¸±“mSW†F
z‚68k—·™²­¸§{‘„oSWg‡°§œ·¨´
–ŠƒX£·«šbTc´¯¢¸±“¦´ª´¸ƒw‘„rsl,
j[$U?vPy’‚rŠ{¹3ºpŠ}oX£·«šbTc´
¯¢¸±“°§œ·¨´–Šƒ¦´ª´¸{‘x„†ŽoSW‡–
¯§¸Ÿv_My’‘u“@\{‘}Œ†oSWu1z}
°§œ·¨´–†%z‚X£·«šbTc´¯¢¸±“Ky|o
–¯§¸Ÿ£·«šbƒq‘§š¶±C‡2ioZ3‡˜Ÿ
«¸¡‡D/o–¯§¸ŸvMIz}x„‡›©µƒq‘®
Ÿ¬•¤žµ ´·“IJz‚r‘SWioSW‡IC„
r€}–¥ —“"7zoX£·«šbTc´¯¢¸±‡¦´ª´
¸†Ž‘?“O^z‚rŠ{p
„z‚ˆoX£·«šbT
c´¯¢¸±“Ky|‘x„†ŽHCT116p53+/+SW†tr‚
! 41.63+ "
(%&'$ !78#2/-504,
78#78+ 7)*
8
˜Ÿ«¸¡9¹46kDaºvy’}‡v[$y’‚to–¯
§¸Ÿ›©µvez‚r‘x„vO^ƒw‚rŠ{pŠ}o‡"n†r‚A†–¯§¸Ÿ
›©µvez‚r‘„rsU?v+’‚rŠ{p
=a4ˆoHSW£·«šb0†Ž€‚(0z}X£·«šbTc´¯¢¸±vLSW†X£·«š
b“¦´ª´¸{‘>5„z‚;Nƒq‘x„“Œ‚Pz}‡ƒqo*‡M&v<)y’Š{p
W-]`ʽ΄ „ No.30 (2009 June) 33
--/&%
913"CG=D@;H=?G:<FH)
$
'AB<=>E
) ([email protected])
JI7285
ÙÜ׳i$¢d=Œ¯v£ÙÜ×d=Œ<l¤…B•Š-
'³:–¯§ £6¡CMs
ž‰®…U$ž¤…ÝØÞ«ÙÜ׻θ̷̻aŸ¦,WQ-£(^\;MŸ¡œŠ¯†ÙÜ×d
=Œ<l£{n¡nbž‰¯zb¤…ÒÖÓÕ3¢ÀÄɾÌͼļ­¢¬œ)”°š†zb¤
R.£ÙÜ×y³qt•A–¯zbž‰¯…7)”°šzb£+x¤ÁÈÌ¿ËÎÅ
Ï"@Ðy³qt•A–¯ÛÛÝ&zbŸ¥°¯ºÂ½´Ã¢0–¯†“‹•šK\hFª‰®…
ÛÛÝ&zb¤Z£]`/ž4‘XŠ­°Š¯…U$N£ÙÜ×d=ŒCM£T
Š
#¤…ÁÈÌ¿ËÎÅy¢¬¯C9£¡ŠÙÜ×ve¢¬¯Ÿ“±+Š†H_ž¤…ÛÛÝ&z
b£
‚PŸ…™°¢G²¯ÛÛß&zb£P³pr•…ÛÛß&zb³X–¯“ŸžT³+
2¢”—š‡O˜¯›’ˆžÙÜ׳d=Œ¯“Ÿ£I¯B•Šd=Œ;MÏÚ×ßàÞMУc³k
ܠ
KIMNL!0#64(
WQ¢~–¯24Š-
'¢Š
…ÙÜ×d=Œ<l¤D1\¢XŠ­
°¯{n¡;Mž‰¯†•Ž•U$4‘
²°Š¯ÙÜ×d=ŒM¤…ÒÖÔÑ
3¢|[”°I…(H\¢¤
a£Ã˾¹ÉU$ª²°®…
>!£%¤*‘L”°Š¯†d=Œ
T£oPŽ­›’ž‰°¥…
Gateway®¡ …U$¨ž¢ƒŠd=Œ
T³w:•š<l¤?*‘|[”°
Š¯†•Ž•…“‹•šd=Œzb³X
Šš<lž¤…d=Œ¼µÎÅ£iY
5”°•¨‹š©…8I£ÙÜ
×d=ŒCM³f=Œ¯¢¤jœ
Š¡Š†“‹•šVYŽ­…m€¡ÙÜ×
¹Ì¼¾Ç¶»Æ̳k‹]`g*‘£
E}³d=ŒJ¢u«•Š¯US
*) 6 ,.+ !0)
s+:x{óã÷§ § No.30 (2009 June) 34
³­Ô©¸ÒǨižÆ<¦JKɕ²ÒÈ
Ç?¹ÂΝ2ÄÆÀ®ԩ
’
8ÈÛô÷èõÜ×ɺÍÄ»ÔÿĂýÈ]ª
ÆQÇɨëÛãÄ*ÊÕÔrmÈêðàíçÿĂý
³t®ÒÕÔø/ú¨`ù©ëÛãÇɨ=~‚Ã
âóÛßïõׅ¯½ÍÈì÷ÚϨˆ‡—6g¨ì
òäÛô÷èõÜÝÙæøāþĄùÆų)ËÕÔ©ëÛ
ãכ”}Ãq»Ô·ÄÃāþĄÈ›”}
ÝÙæ×S¹¨rmÿĂýח®Âw–mÈÿĂý×
CÔ©']ǨÛô÷èõܻԒ
8“øÙõÝ
÷æùΛ”}Ãq¹¨D‰Æ’
8Sj׫
Ó»¬Qׅ¯ø/ú¨`ù©·¯¹ÂCÒÕ½w
–mÈëÛãÄÙõÝ÷æ×ÿĂý€”}À&¸
¼Ô·ÄèvuÇEº½T½ÆêðàíçÿĂý×C
ԷijôÔø/1¨`ù©ÈqÃt®Ô
›”}׈R&¼Ô·ÄèÙõÝ÷æ×nÀ½U
(ÇÌÕÔ·ÄÎ%ƒÃ­Ô©¹²¹¨·¯¹½
AÈÿĂýO°QÉO°o³®½Í¨y
<ÇO°×CÔ½ÍÇÉ]ªÆ@5ׅ¯D‰
³­Ô©°Ê¨›”}q¹½ÿĂýSjןa
d¹¨vuÈÝÙáÈÿĂýSj×-#¹Â|‡¹
½Ó¨ÿĂý€"EȜÈëÛãÄÙõÝ÷æÈ"E
Y×W‘¹½Ó»Ô·Ä³„uDžÖÕÔ©·¯¹½J˜ÈN²Ô\È.ÇÁ®Â>¹ÂÌÔ
Ĩéñõçô÷îÆĀĀă1›”}ÈÓ$³,¤È[fíԷij²Ô©
BµV!¹Â®ÔĀĀă1›”}íÔBamHI×Çéñõçô÷îÈ,¤gׁ°Ôø/ûù©ÿĂý×¢
–öŽ–ÈſҲҋØÃÎ'º“ÄÆÔȳéñõçô÷îíÔø/û¨`ù©¸ÒÇĀĀă1›”}
ÇÑÓS¸Õ½Ó$Îéñõçô÷îÄÆԽͨ°ÊBamHIÃS¹½ÿĂýSjרBamHIS¡
×LÁÈÿĂýǀ&¸¼Ô·Ä³%ƒÃ­Ô©›”}È·¯¹½lF×t»Ô·ÄèÿĂýO°
K†É<p»Ô©¹²¹éñõçô÷îS¡×cHeµŠ>»ÔĨBamHIS¡×X»ÔÿĂýɨ'º
S¡×LÁ­ÒÐÔÿĂýĀ&%ƒÃ­Ô·Ä³²Ô©ÁËÓ¨éñõçô÷îS¡Å¯¹È€"
EÇÉU(F³90¹Æ®©°ÊÙõÝ÷æů¹ø/ü¨`ùÏëÛãů¹È€ø/ü¨`ùÎ%ƒ
íӨ<œÇ·¯¹½€Sj³sI¸Õ,¤ÄÆԷij­Ô©vuÈêðàíç3ÇÎëÛãÄÙõÝ
÷æÈhRÈ&¼³90»Ô½Í¨vuÈO°È#o×W4»Ô½ÍǍÈѯÆQ³D
‰ÇÆÔ©
·¯¹½éñõçô÷î“È^gÇÁ®ÂɲÒMP¸Õ±Ө éñõçô÷î“ÈS¡
×X»ÔĀĀĄ1›”}Ètβ҅ÖÕ®ԩ½¾¹¨8sk:ÈUbŒÇ™»Ô;uÆ
7έӨĀĀă1›”}3ț”}Ép0_Åt¸Õ®Ʈ©UèĀĀĄ1›”}³
ÔS¡ÉHÇåÞÙõ»Ô·Ä³%ƒÃ­Ó¨€ÇU(F×L½¼ÂëÛãÏÙõÝ÷æů¹È
€×š¶·Ä³ZÔø/û¨`ù©Ë½1z¥È”}ÈRÈS¡×Ô·ÄÎ%ƒÃ­Ó¨ĀĀă1›
”}ÈѯǨˆR”}È&¼Ç£×G˼ÔD‰ÎÆ®©
V+^bé×ì˜ ˜ No.30 (2009 June) 35
÷÷û$Œf¼=ÊXª¶š©Å»T¼uŸõøój@¡8ʉ<ª²¼¤šF`·h¬
ÇöóûüúJíöĊăăċ˜ ýĊĉĆĄýĉĂÿ˜ ĈĂąāăĀïĉĊþĀ˜ ćĀÿĆĄþĂąýĉĂĆąî·žÇí"ñî›F>J·½õøó¼B
P¸š÷÷û$ŒfšõøóˆkŒfÊ
¶L¯É®šÓëÐèÕÚÙà·j@¡8ʉ<ª¶ŸÇ›
‡¼Ä ºõøó¼4UÃey¤7z·žÆšE]ðò_2·
/_Êi¡Ç¨¸¤·¥Ç›¿²j
@¡TÃj@¡ÕÎìä¼tY2¼|O£Åš5G¼CJÊ»o¥@¡Ç¨¸¼GÇ>J·ž
Ǜ
öóûüúJ½š÷÷û$Œf¼”ÞçëÜêìä9¸šBŠ¸€Š¼œ­ÈÊXª¶–j
@¡Tʉ<ª¶ŸÇ›ùôúJ·ÍëÒìÛ¸áÏ×¼BPʰȱÈ(0ªšàæÍã»ËØà׋
ʪ¶¢¦¨¸·šùôúWQ»÷÷û$Œf¼€Ší"ñš—v!}îʧǛ÷÷û$Œf
¤õøóʀ¬Çc=¸B¬Çc=½ZºÇŠ·žÇ²Áš€Š£Å,¼'%A³§“Ȳ
c=¼:‹ÊB¬Ç¨¸¤GÇí"ñšlm¼8MK»½õøóˆkŒf¿ÈDzÁš
DƓ©È²ËØà׋¤¼õøóBP»k¬Ç8ƒ¨Ç›¨¼Ä »šõøóBP¼
ËØà׋»Žª¶½šB¸ˆkÊnƆ¬1x8¸ºÇ›¨¼S;·šÍëÒìÛBP¸áÏ×BP
¤ˆk©ÈǸš¨¼õøóBP»½Â½Ã÷÷û$Œf¼€Š¤*#ªºŸ›¨¼²ÁšÍëÒìÛ
¸áÏ×¼ˆkWQ½1x8£Å“rªšEiWQ¼’a¤ƒ¨Ç›¨ ª²1x8£ÅEiWQ¾
¼C[º8¤öóûüúJ¼E)¼R6·žÆš¨È»ÄÆÓëÐèÕÚÙූŸj@¡Tʉ
<¬Ç¨¸¤GÇÄ »ºµ²›
-‘»¨ ª²8ÊI~ª¶ÀǸšùôúdWQÊXŸ²&»½õøóâçåæìÖ¼?´…À»Ä
ÆõøóBP¼1N¤ƒ¨Æšõøóˆk8¼RZ9¤¬Çº¹¼
•¤V«²›¿²šùôúde
yWQ»½ùôú¼ÚëàéìÛõøóÂ*#¬Ç²ÁšöóûüúWQ·)swÊ3‚„@¬Ç¸šÚëà
éìÛõøóYG¼Ñêݤ3<©ÈÇ
•Âžµ²›p¼
•»Žª¶½š\Hgq¼õøóâçåæì
֙¼.·žÇËßÌÔÑç뤚gwYG¼ùôúXõøóâçåæìÖÊTĦ.¬Ç¨¸Ê{
a%2koïÛó No.30 (2009 June) 36
§¹³¢P
>À©Ï±½¼þăü9YÁ&œÂ‚UÑǸ£Æ¸¢ßñåïóàþăüÀ4³»Â¢ê
ÝîþăüÁ‚‘r¼¦Ï Ă¼Ąýąb\Ñ`´Ï±½¼¢ßñåïóàþăüÁ;™ÑE•´Ï
±½«Q¸£ĄýąÁßñåïóàÀc§»§ÏåìÙèáþăü¢/{}¼"B²Ð¸ÊÁ¼¦Ï¸É
êÝî²Ð»§Ï«¢ĀüĆćą«uG©ÏÁÂĄýą¼-8²Ð¸þăüI[¼¦Ï¸ÉêÝî²л
§¿§£±¨³¸þăüÁžÁ7Ñc³»=¿þăü1ÁÇэ´Ï±½ÀÌ΢ĀüĆćąVÁ
_Â/¬®$³¸£
Mtb\ÃK$gÀ
>«‹ÈJ³§uG©
>À¢Ąýąqb\ÑiFc§Ï¸ÉÁ60Ñ©
ϱ½¼¢¤WµÏ¹¯¥¼þăüuG©Ñ~¨ĀüĆćąVѓf´Ï±½«Q¸£‘rxÑ©»øúÅ
¾Á—wÑ~¨¹¯¼û÷ôm:ÁuG©_ьB³»ªÎ¢PCVÁŸ§|d:ÊyA´Ï½¢<QÁ
uG©KVÑw¬G©Ï¿?zÑN´Ï½y©»§Ï£
±±Æ¼Á…Ñƽɻ¢3–ÀþăüuG©Ñ~¨¸ÉÁåðàÖîÑÀs´Ï£¤WµÏ¹¯¥Á
åðàÖî¿Á¼RCš½³»Âj§«¢ÁZÀe@´Ï=«¦Ï£›¼Ê‰Ä¸½ªÎ¢ĂĂĆ
”‘rÁI«ãíñáðóéÀ¿Ï½¢Óñ×óàËæÔÛ¾¨³ÁìÓÕóØëñ«ˆ±Ï¸É¢±Ð
Ñ'Ž´Ï„ƒ«=¼¦Ï£Æ¸¢ìÓÕóØëñX:Ñ°´­¸Î¢Ąÿā¿¾ÁìÓÕóØëñ
Ñ
º¸Î´Ï½¢èÙçÞÝòìÓÕóØëñ«-©»hgb\Á!’««º»³Æ¨£ìÓÕóØëñ
_Ñ.5^]À³»Ê¢ìÓÕóØëñÁTl?Ñ´ÏĬ¼¦Ï£ åìÓçÁ„ƒ åìÓçÁ*PSŠ½³»¢ú¡OpÀH,*m:Á½ĂĂĆ)”‘rÁ†‡½ÑÄ¢²
ÍÀIÑDÒ¼ù¡ÀßñåïóàÃÁâÓäíÜÓÚóØëñÑ„¯Ïõ(úö£Óñ×ó
à½æÔÛÀ4³»¶Ð·ÐåìÓçфƒ³¢ĂĂĆ)”‘rÀÌÏI˜¾¨³«¢¨Æ®v"´Į̈À
„ƒ´Ï£€HI[Á#LìÓÕóØëñÑ~¨+"À¢IÑ€Hnc@³¢¶Ð·Ð«ÔðÙ
àóÔ³¿§Ì¨Àe@´Ï£ /(1 No.30 (2009 June) 37
;9>?=
42 4! <:=$
52 <:=$5! # 47A83"
62 ;9>?=
7μ@ 73μ@!&0+)0*$*.0',%1-"
μ'
GAK<CF7EW+(*'μ'X
μ'
?JCIK@ W)%μ'X
μ'
0+'/-A>B4
μ'
#-W(X
μ'
%
W(X
μ'
+'/-W*1*"*X
μ'
VT
μ'
NU
μ'
2
M
:78H
2
S
2
S
Y :78H
2
M"+
2
M
:78H
! !)%* A>B4W$,($).!-X
0.5μ'
&%!-$ A>B4WX
0.5μ'
RQW7J:K@X
1μ'
RQWD8=X
1μ'
5B6;9GJW(3OL X 0.2μ'
W(X
1μ'
%/W$,($).!-X
0.2μ'
+)WX
0.2μ'
'&%!-$(&''&*) ('WX
0.2μ'
VTP
5.2μ'
NU
10μ'
1. Kotera, I. et al., J. Biotechnol. (2008)137:1-7
17:‡u‹M M No.30 (2009 June) 38
2nd Switzerland-Japan Biomolecular Chemistry Symposium ŒSJBCS2009
http://www.cbl.rcast.u-tokyo.ac.jp/FBC/SJBCS2009
*;8"?7:t‰u‹Š%)~ˆ‰xih17:
(2009 9 ' 11 %(F)12 %()
*L…p‹vmƒ‰}sŠo‰‰q„‰€‹†ŒAn +
http://www.cbl.rcast.u-tokyo.ac.jp/FBC/SJBCS2009MAP.html
twq„‰
1. Mechanisms and Engineering of Biomolecules
2. Biological Probes and Therapeutic Methods
3. Natural Product Synthesis and Engineering
4. Biological Sensors and Systems
^C0=Œ#92
sjsStefan Matile, Howard Riezman (U. Geneva), Hilal Lashuel, Karl Gademann, Kai Johnsson, Bart
Deplancke, Christian Heinis, Horst Vogel, Ursula Röthlisberger (EPFL), Jean-Louis Reymond (U. Bern),
Don Hilvert, Dario Neri, Karl-Hein Altmann (ETH), Nathan Ludtke (U. Zurich), Helma Wennemers, Marc
Creus (U. Basel)
%)Toshihiro Ihara (Kumamoto U.), Shinsuke Sando (Kyushu U.), Takashi Morii (Kyoto U.), Junko
Ohkanda, Koichi Fukase, Tomoaki Matsuura (Osaka U.), Teruhiko Matsubara (Keio U.), Takeaki Ozawa,
Hiroshi Murakami (U. Tokyo), Takayuki Doi (Tohoku U.), Takeharu Nagai (Hokkaido U.), Mikiko Sodeoka
(RIKEN)
sjsN%)_RP[N1Žz{|jkˆr‹Nn‚l†|jkˆr‹K\&;`7:g
HW[Pf-G`7:=S_WN~ˆ‰xih7:g<Xf]]d_
`K3_ZP[D
BXfT]g64]W[PbXO17:g…‹yXfI`.g/cN
_EA^$!g
Qf_^Y[PbXO>3@]W[su‹3@dJW[RebXO5,afY[UV
PO
L )TW«Ÿ®x x No.30 (2009 June) 39
¦ Ÿ ®O cN m ­ 3 m | ³8 < 7 7 ¯p °
¦ Ÿ ®O c ‹s ³
_jI‰„‡¦Ÿ®Oc”
…{Oc.=^ŒzA4 KMY±¤®œ]¯,Š 2.5 cm ‹
Q°ŠzvR­Oc^¯o‹&ŒOc^Š\°­2+­2#$¯o[°z‘Že8>4”fl
„zt(¨®ª¯Microsoft wordzˆ€“ PDF £•—ªˆH
;w°ˆfNmˆn’ƒ~{
k¯e 8s Xm  °³
¯_°3m 10,000 z07 11,000 ¯)L°3m 2,000 z07 3,000 3mzPq6CŒf–¡«Š‡‚Uiƒ~{
–¡«³http://www.cbl.rcast.u-tokyo.ac.jp/FBC/SJBCS2009_registration
" †­N m ³
}277y8562x aS@-@‹a²y±y²x L
B 301
?')')r5u%1V)TWVx x D>x F/
tg³04-7136-5402x FAX³04-7136-3601x
E-mail³[email protected]
hZŒ¥®§¤®œ³http://www.cbl.rcast.u-tokyo.ac.jp/FBC/SJBCS2009x
g³`x d9¯c°zD>F/¯*°x
ž ›©¬˜®™¢—š®³b:zE$x AzGJFz!
o3#@z~ç×ë¦ ¦ No.30 (2009 June) 40
% !"(*
https://apply.reedexpo.co.jp/IPBI/jp/form_con/step1.phtml?ex_code=TOKU
^`ï2009 I 7 a 2 ^¦ 10:30ð12:00
9UïfàØÒÓÌÚ
‚ êq •ï https://apply.reedexpo.co.jp/IPBI/jp/form_con/step1.phtml?ex_code=TOKU
!"(*-¦ ¥±o&u»°Éku¾˜# ðÛÝÞÌÏz~°W±ce&uð
Jžï0-D;@ „žìz~VLíêG@z~|\Z¦ ¤9 6
¦ ¦ ©°É‚‡¾ÌãëÕéÒ*À°Éku½1²¶ÛÝÞÌÏz~ª
f$;@;@ ¦ &@€z~| :|sR@‘J ‰t:|@›¦ \Z¦ ; S_
¦ ¦ ©^dv ‚‡ÔëÚ ÙËØÔåÎéÕÜÊæéÒ¦ ðo&upg
Á¾YTðª
f=?&|;@¦ o3&|@z~U Užê\Z¦ E› <
*& '+ %#$) ,*& '
http://seitai.csj.jp/div_sympo/
ï^d#@ohˆŸ—#@š§^d#@ÞÌÏÙÑÝèÕëš
ï^d#@§#@G@ÞÌϚ§F;@ GîCOE ce?ÔÖÙâ#@\†z~Xn
bï9 a 13 ^ì^íì13 `íð15 ^ìmí
9ïF;@&€ÐäéßÖêxIŽQ‘8ì«812-8582 {EHf%¤ 3-1-1í¬–­{EH57
œ¤;s Oi 5 )! q• …  8 a 3 ^
vŒ q• … ï6 a 22 ^ìaí
} (} … ï7 a 21 ^ìmí
)! w ì í… ï8 a 3 ^ìaí
ohˆŸ—#@šÔéáÕÍâï
vŒMKï,¢ì15 vŒ§5 ”r§2 9í¯ÄÀáÖ×ëvŒ
*,¢vŒ¿(»´¹ 1 z~B 1 º¨´§q•¿ 2 º.¨³¾9/¿§vŒ¡È¸²§
2 y¾[2¿A‹>4¾]½Äƨ
š‘l“ïohˆŸ—š*ÀÞÌÏÙÑÝèÕ뚾š4½¼·¹ 1 I
°ƒ™´§+“
` 40 j
¾š4°C’¨“P"q¿vŒq•`nºw¨
ÞÌÏÙÑÝèÕëšÔéáÕÍâï
vŒMKl¯ÄÀáÖ×ëvŒ
*9 a 13 ^ï'N 1 `Äől죑l¾Ã§Š¾,¢vŒ¿‹Ç¼®í
)!w¿–»¼·¹¯Åµ¾º§ÔéáÕÍâ½)!.ˆºµ¨
4;?nhpR R No.30 (2009 June) 41
HR KsB 5,000 S4 3,000 SQKsB 7,000 S4 5,000 S8 . 3 -NS
=\ 2,000 jmg
'Fs9 . 14 -q.rTH5 6,000 q%Y\7J]rT
7J,1seokfcl[_SWEB dbiqhttp://seitai.csj.jp/div_sympo/rV`9D7JS>>]
+S:L]X^Z]*AWaCUT
7J s
812-8581 <#/@
6-10-1R !
3I;?)R R (6 $R
PGs(092) 642-2731R
FAXs(092) 642-2715
E-mail: [email protected]
http://seitai.csj.jp/div_sympo/
s
819-0395 <#E 744 8R !";?O&5KMR R 20
PG/FAXs(092)802-2850
E-mail: [email protected]
http://seitai.csj.jp/div_sympo/
R
RR RR
R
R
{/!?†‰ĕĆęÈ È No.30 (2009 June) 42
http://www.geocities.jp/y_glycosci/
nçʍ½¶æ!?ĘK?Ę{!?Ę{y?‹õ†‰E¯ãÛóš^†‰’Òðé?{æ
væ
âÛËisç
væäÐqÌä¸æ†‰’åðòʍ±õˆ?Óà;¤å­«âÕôèãYßá
ÒòëÛËæ_V¬wõғÕÚÝWʬNæ{bõÒ4ìÚÝ[£Ê$’åðó(Â%çď
ĄĆꀜ쀜UTçFêXÙÐË?ãçäòëÛæâʸæbåïz¥âÕóðÑ
åÒÄЗÚëÛËĜ‹ÊBç®DâÛËëÝÊoåÒ
îæbâÚÝñ31æ©eâïpÐëÜöË
ÆæÏ󆉒攛ãÚáæ$ïr´ÚáÒòëÛˍ±õýęĖęĈåaÝ䆉õH¼ÚÊaÚ
Жõ6ÑÕßÓÖåäôèQÐâÛËgÁÊÒt²åX$ÙÐËÈ
ĥFCCA
dhĥġğğĤPģjġģdě¹ĜīġĤdě5Ĝ
9ĥàóëÐČĒāěZ„ƒ
ÅĜÈ Šġ ”¡A
Z„ƒ-)GLf0"ǘĠ‚ġ~Ģġ+ěÀ§ĥ(052)733-1141Ĝ
ěhttp://www.ailabor.or.jp/tmplaza/Ĝ
BĥÈĠĞ_V¬wÈ
È
ºmS=È {ě·<ĜÍ÷ėĊĔùėāø÷ĔĄã»ÎÈ
È
…|‡uÈ {ěI¾<Ĝ͞¿äpµõkÛóüėþēûĂĈæŒC,\ÎÈ
È ġĞš^†‰’ě?{ï.íĜåðó™¬w&éďĄĆꀜÈ
È ĢĞ
vÈ
Ć÷đćęċĔĥ ĦĠd‚ħ
10:15īÈ '¼>
#È _V¬w
#WÈ (€œ
:bÈ ďĄĆꀜĚ[£
È
Ħġd‚ħ
#È _V¬wĝ(€œě12:00 @Ĝ
@2ĥ50 $°ĥFCCA 2È x`ÊÁ2È ™ 2,000 Ê?{ 1,000 c°}ªĥnĪĩĩĨąĐĉęêæ$’çJ(7¹ěhttp://www.gak.co.jp/AN/kkfundJ.htmlĜÓñæc°
æ}ªÔ*•âÛË
}³ ‘ĥO\ 21 P 7 j 31 dě¹Ĝ
É(ÂÏóÐçďĄĆęæMlʀœÃ‚õe¦æʦæœRê E-mail âÒ}Ú
³ìÙÐË
}³ ĥ·<?È {/Sˆ?†‰]È |ìÞóěE-mail: [email protected]Ĝ
¨ŽçĎęđčęăěhttp://www.geocities.jp/y_glycosci/ĜâïØ¢åäó×ãÔâÕëÛË
š^ĊúęĒđœÈ 8È Ÿě·<ĜÊþĒ÷ÿĀ÷ùėĄš^æÈ œR |ìÞóě·<Ĝ
@
FIyx{i i No.30 (2009 June) 43
|LedFIHi *}i
+_HPU#S&HM]i
k598rXZOv/pu,W4O$1aVtFIli
|20094.14-j%21!H'Tct+_HPU#"sonq]}i
b R*N_ Q<H*Nwzx{
Y
m228-8555 GED2b 1-15-1
E-mail: [email protected]
0di K+
FIHi
H)i @?HJi *(
m153-8902 0`Cgf 3-8-1
Tel: 03-5454-4458
E-mail: [email protected]
h[ >_ =^
Hi *(
m520-2194i :\E7;A6B3[ 1-5
Tel: 077-543-7469
Fax: 077-543-7483
E-mail: [email protected]
^"0fjÑËӋ ‹ No.30 (2009 June) 44
‹ +ƒ6+°‚4œÃ»½s†-#Â<r–Œ& ±ž·©FBCÑËÓ°s†ÂF=œ¡©¤¥•µ
¤ÀÀ«D¿­¤·®*—°K“¼°ÆÎÓ̐¤¥•µ¤”Œšš® No. 30 ’3˜ª•¾
»‘®­½Œs†-#
%꒽µŸ'mt°KŽ®±’AŒ¢¿£¿¤³Ãv!W
2°{
›G¤¥•¯©’gÂ`™µŸ
‹ ššŒ5ª±R‡½¤®¸““Á¼ Œš¿µª´«Ã¬‡¼‡¸„¼ Œ)°U~Â@€
©’½µ¤”Œ¹§«š°JLŒ†c®Y‡”„½µ¤š°J9°5°)°‡±šÃ­Cž
ªŸš¿¸ac­T(°>ˆªº‘“Œ5±¸±¹]7®­½¨¨¾»‘ªŸš°/o
”pÁ½Œ)¶M˜®±0ÇÓÊҍ¢°Z¾°”ŒPÍÐÓÉÑËÓª¸’e¼¡©’½µ
Ÿ«’½ŒQ+ wœÃŒVPœÃ°’|ªPfj”Ÿ¾lÖ&ÉÄÉLP^"0ÇÒÎÈÅÏ
Ô2nd Switzerland-Japan Biomolecular Chemistry Symposium ÔSJBCS2009ÕÕªŸdœÃŒ,§©›
—¥œµŸ»‘’Š`™µŸ
‹ SÔNo. 31Õ±Œ}œÃ°F=®»½Œ2009910N‰°bxÂ1©’½µŸÍÐÓÉÑËÓH$
°¤·ŒdœÃ“¼°›yOŒ›Bzn’?¦©’½µŸ{s†F=µª›q¤¥˜¿²
:ªŸ
8E2196N24L
I
\P+0+0…u[i0fji
Ô[email protected]Õ
s†F=
}‹ Ô+ƒ;k+0Õ
+h_X.Ô+ƒ+0Õ